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ABBREVIATION
Hb Haemoglobin
Hct Haematocrit
WHO World Health Organisation
LBW Low Birth Weight
IUGR Intra Uterine Growth Retardation
IUD Intra Uterine Death
MCV Mean Corpuscular Volume
GA Gestational Age
ICH Intra cranial haemorrhage
SGA Small for gestational age
CLD Chronic lung disease
BPD Broncho pulmonary dysplasia
RSV Respiratory synctial virus
HbsAg Hepatitis B surface antigen
SD Standard deviation
CMV Cytomegalo virus
PPHN Persistent pulmonary hypertension of newborn
PRBC Packed red blood cells
TRALI Transfusion associated acute lung injury
GVHD Graft versus host disease
HSCT Hematopoietic stem cell transplantation
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INTRODUCTION
       The umbilical cord blood haemoglobin is an important
haematological parameter in newborn.1 In developing countries upto 50%
of children become anaemic by 12 months of age.2Mothers who had
anaemia were more likely to deliver anaemic babies.3
       Maternal anaemia has several deleterious effects on the health of
the mother and fetus.4About 50% of women do not have adequate stores
for iron during pregnancy.5Because the iron required for pregnancy is
more,risk of anaemia increases with gestation.6Maternal anaemia may be
caused by decreased iron supply, increased iron requirement by growing
fetus and by expansion of maternal plasma volume.7
        According to WHO, hemoglobin level less than 11 gm% is defined
as Maternal anaemia during pregnancy.8 Maternal anaemia in pregnancy
is classified as mild ,moderate and severe anaemia with Hb levels being
10 to 10.9 gm/dl, 7 to 9.9 gm/dl and <7 gm/dl respectively.
           The birth weight of infants born to women with anaemia was low
compared to infants born to non anaemic mothers.9Incidence of pre term
delivery and birth of IUGR babies, IUD (Intra uterine death) were more
in women with maternal anaemia.10
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EPIDEMIOLOGY
       Anaemia is a commonest medical disorder and around 50% of
women become anaemic during pregnancy worldwide.Maternal anaemia
during pregnancy is common in developing countries which affects 57%
of pregnancies.11,12
          Umbilical cord blood is  the most valuable underutilized resource
in the care of neonates. Utilization of umbilical cord blood for laboratory
testing of neonates is a promising new practice which has shown to
improve neonatal outcomes. Full implementation of this practice is
therefore an important step in better utilization of umbilical cord blood in
improving the outcomes of neonates.13
HAEMOGLOBIN STRUCTURE:
      Haemoglobin  is  produced  inside   in  the  red  bone  marrow.  It  is  a
conjugated protein comprising of  Haem and Globin. Iron and porphyrin
compound in haem constitutes 4% and Globin compound constitutes
96%.14
        Iron ion along with porphyrin forms haem compound. Porphyrin
is an heterocyclic ring.  Four pyrrole molecules with protoporphyrin
linked together cyclically by methane bridges.15  Metalloporphyrin is
formed by combination of metal iron with protoporphyrin.
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Metalloporphyrin  consist  of  0.34%.  Iron  (Fe)   in  ferrous  state.
Haemoglobin  consist  of  tetramers  with  two  polypeptide  chains  of  one
kind  & two of  another.  Haem keeps  iron  in  ferrous  state  by  globin  & it
combines loosely & reversibly with Oxygen.16
       In normal adult Hb  (HbA-globin)  chains are called ? and ? chains
and in HbA2 –? and ? chain are present.  In each chain there are about
150 aminoacids in sequence. The substitution of any one of these amino
acids  by  another,  results  in  formation  of  abnormal  chain,   In  sickle  cell
anemia,  Hb S is present in which glutamic acid is replaced by Valine.17
     Synthesis of Haemoglobin :- Synthesis of Haemoglobin begins at the
erythroblast stage and then through normoblast and reticulocyte stage .
Formation of haemoglobin occurs in ribosome of endoplasmic reticulum.
Haem portion of haemoglobin is synthesized in the following steps:
Formation of Haem
? In Krebs cycle, acetic acid changes to ?- Keto glutaric acid which
then combines with Glycine  forming Pyrrole compound.
? Four Pyrrole compounds combine to form Protoporphyrin III
compound.
? Protoporphyrin III + Fe ---------Haem (Metallopophyrin)
Formation of Haemoglobin 18-20
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? four Haem molecules + Globin --------- Haemoglobin
        The most common haemoglobin type is a tetramer which is
haemoglobin A in adults. Two ? and two ? polypeptide chains (?1 ?1 and
?2 ?2 ) noncovalently bound, each made up of 141 and 146 amino acid
residues respectively, in globin chain of Hb A. Abnormalities in the chain
alter the physical characteristic of Hb.
          In human fetus,Fetal Hb (?2,?2)  during  the  last  seven  months  of
development in the uterus  persists in the newborn until roughly 6 months
old is the major transport protein. Fetal hemoglobin is nearly completely
replaced by adult hemoglobin by approximately 6 months postnatally in
newborns .21
         Fetal hemoglobin differs from adult hemoglobin in that it is able to
bind oxygen with greater affinity than the adult form, so that it  gives the
developing fetus better access to oxygen from the mother's bloodstream.
Level of foetal haemoglobin decreases after birth. The normal level of
foetal haemoglobin in adults is usually less than 2%.
Haemoglobin A is the major haemoglobin in humans:
Haemoglobin A2 first appears at 12 weeks after birth. Normal level of
haemoglobinA2 is 3-6 percent.22
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HAEMOGLOBIN GLOBIN CHAIN
Haemoglobin A ?2 ?2
Haemoglobin F ?2,?2
Haemoglobin A2 ???2
Haemoglobin A1c ???2-glucose
The oxyhemoglobin dissociation curve is useful in recognising
how the haemoglobin delivers oxygen to the tissues.  In oxy dissociation
curve  oxygen saturation (SO2) and partial pressure of oxygen in the
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blood (PO2)are  the  two  parameters  involved.  This  is  a  S  shaped  curve
which denotes the affinity of haemoglobin.
At  partial  pressure  of  oxygen  of  60mm  of  hg,  the  oxygen
dissociation curve is flat. Even the partial pressure of oxygen increases
above 60mm 0f hg saturation of oxygen is not altered  significantly.23
Factors influencing  Standard Dissociation Curve24
Oxygen- hemoglobin binding can be influenced  by several factors.
These factors have an influence  on shifting  the oxyhemoglobin curve  of
an healthy person.  Shift to right of the curve is caused by
? increase in temperature,
? increase in 2,3-DPG concentration
? increase in PCO2
? decrease in pH.
The curve is shifted to the left by the following factors
? decrease in temparature
? decrease in 2,3-DPG concentration
? decrease in PCO2
? increase  in pH
18
 A  rightward  shift  means  there  is   decrease  in  the  hemoglobin
affinity for oxygen. Higher partial pressure  is required to achieve the
same oxygen saturation.When the oxygen dissociation curve is shifted to
right , hemoglobin have reduced affinity of oxygen . Conversely,  shift to
the left  increases the affinity of oxygen. So  that it is easy for the
hemoglobin to release  the oxygen to the tissues.
Variation of the hydrogen ion concentration
A  decline   in  pH  shifts  the  standard  curve  to  the  right  while  an
increase  in pH shifts it to the left. This is known as the Bohr effect.
? Effects of carbon dioxide.  The curve is affected by carbon dioxide
in two ways:
1. carbon dioxide  affects  intracellular pH (the Bohr effect),
2.  CO2  causes generation of  carbamino compounds through
various  interactions.
Reduced levels of carbamino compounds have an effect of shifting
the curve to the right, while higher levels cause a leftward shift.
Effects of 2,3-DPG. 2,3-diphosphoglycerate, or 2,3-DPG, is
produced  in erythrocytes during glycolysis. This compound is an
organophosphate. The generation  of 2,3-DPG is likely an important
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protective  mechanism, because the 2,3-DPG production increases for
several conditions in the presence of reduced peripheral tissue
oxygenation. High levels of 2,3-DPG shift the curve to the right. In the
following conditions there is high levels of 2,3-DPG.
o hypoxemia,
o chronic lung disease,
o anemia,
o congestive heart failure
Low levels of 2,3-DPG cause a leftward shift, seen in states such as
o septic shock
o hypophosphatemia.20
Temperature:
? Temperature does not have dramatic effect as the previous factors,
but hyperthermia causes shift of the curve to the right, while hypothermia
causes a leftward shift.
? Fetal Hemoglobin. Fetal hemoglobin (HbF) is structurally different
from normal hemoglobin (Hb). The fetal dissociation curve is shifted to
the left relative to the curve for the normal adult. Typically, fetal arterial
oxygen pressures are low, and hence the leftward shift enhances the
placental uptake of oxygen.20
20
? Carbon Monoxide.
       Haemoglobin has very high affinity to  carbon monoxide than with
oxygen.  Haemoglobin is able to bind 240 times  more readily than with
oxygen.The presence of carbon monoxide can interfere with the
hemoglobin's acquisition of oxygen. In addition to lowering the potential
for hemoglobin to bind to oxygen, carbon monoxide also has the effect of
shifting the curve to the left. When  carbon monoxide levels are increased
a person can suffer from severe hypoxemia while maintaining a normal
PO2.25,26
? Effects of Methemoglobinemia
It is a form of abnormal hemoglobin. Methemoglobinemia causes a
shift in the curve to the left.
MATERNAL ANAEMIA IN PREGNANCY
            Maternal anaemia during pregnancy is very common in
developing countries which has several deleterious effect on the
foetus.27It is considered as risk factor for poor pregnancy outcome and it
can threaten life of both mother and foetus. Prevalance rate of anaemia
during pregnancy are variable according to WHO because of differences
in lifestyle,food habits and socio economic conditions.28
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           According to WHO, haemoglobin level below 11 gm% in
pregnancy is considered as anaemia. Maternal anaemia in pregnancy is
classified as :
                 Mild anaemia -       Hb level  (10 to 10.9 gm/dl)
                 Moderate anaemia -         Hb level  (7 to 9.9 gm/dl)
                Severe anaemia -        Hb level  (<7 gm/dl)29
PREVALANCE OF MILD, MODERATE AND SEVERE ANAEMIA
In maternal anaemia,the number of red blood cells and their
oxygen carrying capacity is insufficient to meet the physiological needs
which occurs either due to defective RBC production,increased RBC
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destruction and blood loss during pregnancy. Risk of anaemia increase by
four fold from first to third trimester when monitored by centre of drug
control(CDC) as part of pregnancy nutritional surveillance.30
             Haemoglobin levels decrease progressively in pregnancy because
of hemodilution and increasing needs of iron and other nutrients for both
mother and fetus. While in third trimester, hemoconcentration occurs
which results in higher haemoglobin levels.31
Many women undergo higher risk for anaemia because of increase
in iron need during pregnancy.13When pregnancy progresses,iron
requirement for fetal growth rise in proportion to weight of fetus.32
            Anaemia during pregnancy ends up in impaired growth and
mental development in children. There is a strong association  between
low maternal Hb levels during pregnancy and adverse fetal outcome.33
Classification of anaemia:
The anaemia may be classified in various ways. For all practical
purposes,simplified classification is given which is helpful in the
management of cases. Not uncommonly,an atypical form of anaemia may
be met with and in such cases,the opinion of a haematologist should be
sought for.
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? Physiological anaemia of pregnancy
? Pathological
    Deficiency anaemia(isolated or combined)
? iron deficiency
? folic acid deficiency
? vitamin B12 deficiency
? Protein deficiency 34
Haemorrhagic
acute : following bleeding in early months or antepartum haemorrhage
chronic:hook worm infestations,bleeding piles
heriditary
thalassemias
sickle cell haemoglobinopathies
other haemoglobinopathies
Bone marrow insufficiency- hypoplasia or aplasia due to radiation ,drugs
Anaemia of infection(malaria, tuberculoosis)
chronic disease or neoplasm 34
24
Concept of physiological anaemia
During pregnancy there is a dispropportionate increase in plasma
volume, RBC volume and haemoglobin mass. In addition there is a
marked demand of extra iron during pregnancy especially in the second
half. Even an adequate diet cannot provide the extra demand of iron. Thus
there always remains a physiological iron deficiency state during
pregnancy. As a result there is not only fall in haemoglobin concentration
but there is  also associated low serum iron, increased iron binding
capacity and increased rate of iron absorption. Thus, the fall in the
haemoglobin concentration during pregnancy is due to combined effect of
haemodilution and negative iron balance.35,36
CRITERIA OF PHYSIOLOGICAL ANAEMIA:
The lower limit of physiological anaemia during the second half of
pregnancy should fulfill the following haematological values:
1. HB-10gm%
2. RBC-3.2 million/mm^3
3. PCV-30%
4. peripheral smear showing normal morphology of RBC with central
pallor37
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Non pregnant Second half pregnancy
Haemoglobin 14.8gm/100ml 11-148gm/100ml
Rbc 5 millioncu.mm 4-4.5 million cu.mm
Packed cell volume 39-42% 32-36%
Mch 27-32 pg 26-31pg
Mcv 75-100fl 75-95fl
Mchc 32-36% 30-35%
Serum iron 60-120 micro gm Slightly lowered (65-75
micro gm)
Total iron binding
capacity
300-350 µgm/100
ml
300-400 µgm/100 ml
Saturation
percentage
30% Less than 16%
Serum ferritin 20-30 µgm/l 15 µgm/l
NORMAL BLOOD VALUES IN NON PREGNANT  AND
PREGNANT  STATE
26
CAUSES OF MATERNAL ANAEMIA
Factors which led to the development of anaemia during pregnancy:
? Increased demand of iron.
? Diminished intake of iron.
? Disturbed erythropoietic function of bone marrow.
? Pre pregnant health status.38
Increased demands for iron during pregnancy:
The daily requirement for iron during pregnancy is 14.5-14.7
mg/day. Therefore, 30-60 mg of elemental iron is given daily as
supplementation along with folic acid.39
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Diminished intake of iron:
Because of poor socio economic status, decreased appetite and
vomiting during pregnancy are some of the contributory factors.
Infections, malaria, haemoglobinopathies like sickle cell
anaemia, thalessemia.
Pre pregnant health status:
Majority of women start pregnancy on a pre existing anaemic state
or at least with inadequate iron reserve.40
Multiple pregnancy:
Women with rapidly recurring pregnancy within 2 years ,following
the last delivery need more iron to replenish deficient iron reserve.
Disturbed erythropoietic function of bone marrow:
Pregnancy depresses the erythropoietic function of bone marrow
by competing for the available raw materials such as folic acid, vitamin B
12,proteins apart from iron.39
INVESTIGATIONS:
1. Estimation of Haemoglobin to assess severity of anaemia.
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2. Peripheral blood smear estimation.Eg: in case of iron deficiency
anaemia,microcytosis,anisocytosis and hypochromic vacuolated red cells
are seen in abundance.
3. Blood indices estimation:
Mean corpuscular volume(MCV) and MCHC estimation.
MCV -below 80 cubic microns and
MCHC- less than 30% in case of iron deficiency anaemia.
4. Bone marrow examination: Done to differentiate the type of anaemia.
5. Stool examination:
 Done which may reveal co-existing ankylostomiasis.41,42
COMPLICATIONS OF MATERNAL ANAEMIA DURING
PREGNANCY:
There are several effects on new born baby because of maternal
anaemia during pregnancy.50
                  Increased incidence of low birth weight (LBW) babies.
                  Intra uterine growth retardation of baby(IUGR)
                  Pre term birth of babies.
                  Intra uterine death of babies (IUD)
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PRETERM BIRTH:
Preterm  birth  means  when  the   neonate  is  born  before  the  end  of
the 37weeks of gestation.51
A. Incidence:
Approximately 12.7% of all births are preterm. The distribution of
this group is gradually shifting to a relatively older gestational age
because of a 25% increase in late preterm infants (34 to 36 weeks) since
1990 to current rate of 9.1%
B. Etiology  is unknown in most cases.
Important  risk  factors  of   preterm  and  lowbirth  weight   delivery
are:
1. Poor socioeconomic class measured by family income,geographic
area, social class, educational level and occupation.
2.  Non-Hispanic black  women are more than three times as likely to
deliver an extremely preterm infant (1.9%) compared with non-
Hispanic white and Hispanic women (0.6%).
3.  Women younger than 16 or older than 35  are more likely to deliver
pre-term or LBW infants; the association with age is more significant
in whites than in African Americans.52
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4.  Prolonged periods of standing  and increased physical cavity  may be
associated with IUGR and  prematurity.
5. Multiple-gestation births  frequently deliver preterm (60% of twins
and  94%  of  triplets  in  2005).  In  such  births,  higher  rate  of  neonatal
mortality is primarily due to prematurity.
6. Any maternal illness which may be acute or chronic  is associated
with early delivery.
7.  Previous history of preterm birth.
8. Uterine malformations, trauma to the uterus,  low lying placenta,
 premature separation of placenta, hypertensive disorders, preterm
 cervical shortening, previous cervical surgery, premature rupture of
 membranes, and chorio-amnionitis also contribute to prematurity.
9. Fetal conditions such as nonreassuring testing of fetal well-being,
IUGR, or severe hydrops may require preterm delivery.
10. Inadvertent early delivery because of incorrect estimation of
gestational age (GA) is increasingly uncommon.52
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C. Problems of preterm birth:
They are related to difficulty in extrauterine adaptation due to
immaturity of organ system including respiratory, cardiovascular,
neurologic, gastrological, renal and metabolic system.53
1. Respiratory:
a. Perinatal depression in the delivery room due to poor transition to
breathing.
b.  Respiratory  Distress  Syndrome   due  to  surfactant  deficiency  and
pulmonary immaturity
c.  Apnea due to immaturity in mechanisms controlling breathing.
d. Chronic lung disease (CLD) of prematurity formerly called
broncho pulmonary dysplasia (BPD), Wilson-Mikity disease, and
chronic pulmonary insufficiency of prematurity.54
2. Neurologic:
Preterm infants have a higher risk for neurologic problems,
including the following:
a. Perinatal depression
b. Intracranial Hemorrhage (ICH)
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3.Cardiovascular. Preterm infants may present with cardiovascular
problems, including the following:
 i. Hypovolemia.
ii. Cardiac dysfunction.
iii. Sepsis-induced vasodilation
b. Patent ductus arteriosus is common and may lead to pulmonary over-
circulation and diastolic hypotension .
4. Hematologic.  Conditions  for  which  preterm infants  are  at  higher  risk
in-clude the following:
               a. Anaemia
               b. Hyperbilirubinemia.
5. Nutritional.
Preterm infants require specific attention to the content, caloric
density, volume  and route of feeding.52
6. Gastrointestinal.
Necrotizing  enterocolitis is an important complication of preterm
infants. formula feeds may also precipitate necrotising enterocolitis.
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 7. Metabolic. In glucose and calcium metabolism, are more common in
preterm infants.
8. Renal.
Immature kidneys are characterized by decreased glomerular
filtration rate. preterm infants have decreased ability of the kidneys to
excrete water and solutes and so the   fluid and electrolyte administration
should be monitored continuously.
9. Temperature regulation.
Preterm infants are especially susceptible to hypothermia and
hyperthermia.55
10. Immunologic.
Because of deficiency in both humoral and cellular response,
preterm infants are at greater risk for infection than are term infants.
11. Ophthalmologic.
Retinopathy of prematurity may develop in the immature retina of
infants <32 weeks or with birth weight <1,500 g .55
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INTRA UTERINE GROWTH RETARDATION (IUGR)
Definition:
Though many use the terms “small for gestational age” (SGA) and
“intrauterine growth retardation” (IUGR) interchangeably, they refer to
two  subtly  different  populations.  SGA  describes  a  neonate  whose  birth
weight or birth crown-heel length is <10th percentile for GA or <2
standard deviations (SD) below the mean for the infant’s GA
(approximately the 3rd percentile for GA).56
IUGR describes diminished growth velocity in the fetus as
documented by at least two intrauterine growth assessments. Babies who
are constitutionally SGA are at overall lower risk compared to those who
are IUGR due to some pathologic process.57
Potential complications related to IUGR:
i. Congenital anomalies.
ii. Perinatal depression.:Perinatal/neonatal depression  is a clinical,
descriptive term that pertains to the condition of the infant on physical
examination in the immediate postnatal period (i.e., in the first hour after
birth).
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The clinical features of infants with this condition include
depressed mental status, muscle hypotonia, and possibly distur-bances in
spontaneous respiration and cardiovascular function. This term makes no
association with the prenatal or later postnatal  condition, physical exam,
laboratory tests, imaging studies, or electroencephalograms (EEGs).
iii. Meconium aspiration: Acute or chronic hypoxia and/or
infection can result in the passage of meconium in utero. In this setting,
gasping by the fetus or newly born infant can cause aspiration of amniotic
fluid contaminated by meconium. Meconium aspiration before or during
birth can obstruct airways, interfere with gas exchange and cause severe
respiratory distress .58
iv. Pulmonary hemorrhage.
v. Persistent pulmonary hypertension:
Persistent pulmonary hypertension of the newborn (PPHN) is
defined as the failure of the normal circulatory transition that occurs after
birth. It is a syndrome characterized by marked pulmonary hypertension
that causes hypoxemia secondary to right-to-left shunting of blood.
PPHN is often associated with the following signs and symptoms
of perinatal distress:
36
? Asphyxia,Tachypnea, respiratory distress,Loud, single second heart
sound (S2) or a harsh systolic murmur (secondary to tricuspid
regurgitation)
? Low Apgar scores,Meconium staining,Cyanosis; poor cardiac
function and perfusion,
? Systemic hypotension and Symptoms of shock.56
vi. Hypotension.
vii. Hypoglycemia from depletion of glycogen stores.
viii. Hypocalcemia.
ix. Hypothermia from depletion of subcutaneous fat.
 x. Dyslipidemia.
 xi. Polycythemia.
xii. Neutropenia.
xiii. Thrombocytopenia.
 xiv. Acute tubular necrosis/renal insufficiency.58
Management of maternal anaemia:
Preventive measures to prevent anaemia need to be considered
when diagnosis is made.
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1. Proper counselling to avoid frequent childbirth.Atleast 2 to 3 years
gap is needed between pregnancies.
2. Prophylactic iron therapy is given during pregnancy.
It is recommended that 100 mg of iron and 500 µg of folic acid must be
given to all pregnant women in second and in third trimester of
pregnancy.43
Treatment:
Depends on the degree of anaemia and period of gestation at diagnosis.
        If pregnant women is severely anaemic and period of gestation is
near term,she requires blood transfusion.In anaemic mothers blood
transfusion is associated with risk of congestive heart failure and preterm
labour.So it is better to transfuse packed cells slowly under cover of a
diuretic.44
Oral treatment:
           Ferrous salts are found to be better absorbed and more effective.
Ferrous sulphate,ferrous carbonate,ferrous fumarate and gluconates are
all used in dose of 200 mg three times a day.Response to treatment is
observed by increase in reticulocytes within week of starting iron therapy
and Hb levels begin to rise.45,46
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Parenteral therapy:
This is indicated when pregnant mother is unable to take oral
therapy because of side effects or is non compliant.It is also indicated
when  cases  are  seen  for  first  time  during  last  8-  10  weeks  with  severe
anaemia.47
Intra muscular therapy:
Iron dextran complex is reported to be least toxic when injected
intra muscularly.Injection of iron is given by Z technique (pulling the
skin and subcutaneous tissue to one side before inserting the needle).Oral
iron is stopped at least 24 hours prior to injection to minimise reaction.47
Iron sorbitol citric acid complex is another preparation of iron for
i.m.injection.
Procedure of injections:
After an initial test dose of 1 ml ,injections are given daily or on
alternate days in doses of 2ml intramuscularly.To prevent the dark
staining of the skin,over the injection sites and to minimise pain,the
injections are given with a two inch needle deep in to the upper outer
quadrant of the buttock using a Z technique(pulling the skin and the
subcutaneous tissues to one side before inserting the needle).48An
additional precaution is to inject small quantity of air or saline down the
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needle before withdrawing it.These procedures prevent even a slight drop
of solution to come beneath the skin surface so as to stain it.
Intravenous therapy:
The deficit is first calculated using formula:
2.4×weight(kg) ×(15-Hb of patient)+ 1000 gms
After calculating total deficit ,iron dextran is diluted in 500 ml of
5% glucose as slow intravenous infusion. When reactions like rigors,
chest pain and palpitation are observed drip should be stopped
immediately.48
Before starting infusion, immediate resuscitation should be ready.
Administration of anti histaminic minimises the reaction.
Advantages of intravenous route:
1. It eliminates repeated and painful intramuscular injections.
2. The treatment is completed in a day and the patient may be
discharged much earlier from the  hospital.
3. It is less costly compared to the repeated muscular therapy.
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LIMITATIONS OF INTRAVENOUS THERAPY:
1. as the maximum haemoglobin response does not appear before 4 to
9  weeks,  the  method  is  unsuitable  if  atleast  4  weeks  time  is  not
available to raise the  haemoglobin to a safe level.
2. Contraindicated in cases of previous history of allergic reaction to
parenteral preparations.49
BLOOD TRANSFUSION
Indications of blood transfusion:
1. To correct anaemia due to blood loss and to combat postpartm
haemorrhage.
2. Patient with severe anaemia seen in later months of pregnancy
3. Refractory anaemia
4. Associated infection.47
Advantages of the blood transfusion:
1. Increase the oxygen carrying capacity of the blood.
2. Haemoglobin from the haemolysed red cells can be used for the
formation of new red cells.
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3. Supplies the natural constituents of  blood like proteins, antibodies
4. Stimulates erythropoiesis.
5. Improvement is expected after 3 days.49
Cord blood hemoglobin of the newborn is an important indicator of
anaemia in newborn at birth. It was thought previously what ever may be
the haemoglobin level in the mother ,baby will not be anaemic. Recent
studies are showing a linear relationship between cord blood
haemoglobin and maternal haemoglobin.59
        Studies conducted to assess the impact of maternal anaemia on
cord blood haemoglobin in newborn were done with lesser sample
size.Still further studies are needed to confirm positive correlation
between maternal  Hb levels and cord blood Hb levels in newborn.60 So
this study was aimed to assess the effect of maternal anemia on cord
blood haemoglobin in newborn.
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AIM OF THE STUDY
To study the impact of maternal anaemia on cord blood
haemoglobin of neonates.
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REVIEW OF LITERATURE
            Neonatal survival outcome can be increased significantly by
improvement in the care of high risk mothers and also in neonatal care
and treatment. Better understanding of maternal antenatal factors
including maternal anaemia is necessary to improve neonatal survival
rate.
CORD BLOOD HAEMOGLOBIN
Normal value of mean cord blood haemoglobin is 16.8g/dl.
Estimation of haemoglobin of neonates from cord blood is useful in
diagnosing neonatal anaemia.60
         Mamoury  GH,  Hamedy  AB  et  al,  in  study  in  2003  titled  "Cord
Hemoglobin in Newborns in Correlation with Maternal Hemoglobin in
Northeastern Iran" concluded that no association was found between cord
blood haemoglobin and maternal Hb levels.60
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TABLE SHOWING NORMAL RED BLOOD CELL VALUES FROM 18
WEEKS OF GESTATION TO 14 WEEKS OF  LIFE.116
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          Sweet  et  al,in  UK  in  2001  in  his  study  titled  "Study  of  maternal
influences on fetal iron status at term using cord blood transferrin
receptors "had shown that mothers with iron deficiency anaemia during
pregnancy gave birth to newborns with lower Hb levels.59
Najeeba  C.M  et  al  in  their  study   have  observed  that  18
mothers(36%) had mild anaemia with haemoglobin value between 9-
11g/dl,2 mothers(4%) had moderate anaemia with haemoglobin value
between 4-7g/dl,and only one had very severe anaemia (<4g/dl).29
(58%)mothers had normal haemoglobin level.The cord blood
haemoglobin values reduce as the haemoglobin level of the mother
reduces,but the reduction is not statistically significant.The mean birth
weight reduces in babies born to moderate anaemic mothers.
Nadia Mudher-Hilli et al, in 2010 in their study titled" The Effect
of Maternal Anaemia on Cord Blood Haemoglobin & Newborn Birth
Weight" done in Department of Gynaecology Obstetrics/ College of
Medicine/ Babylon University stated that there is a positive correlation
between maternal haemoglobin and fetal cord blood haemoglobin.61
          Aarthi  s,kusam  M,  Satnam  S  et  al,  in  2013  conducted  a  study  in
Gian Sagar Medical college and hospital,Rajpura found that cord blood
haemoglobin appears to show a linear relationship with maternal
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haemoglobin  with cord blood haemoglobin being less in mothers who
have anaemia.Mother who had severe anaemia had babies with lower
cord blood haemoglobin.62
          Debbarmarubi et al, 1n 2015 conducted study at regional institute
of medical sciences, imphal, department of physiology in collabaration
with obstetrics & gynaecology department titled "Effect of Maternal
Anaemia on Cord Haemoglobin And Birth Weight of Newborns" found a
linear relationship between maternal haemoglobin, cordblood
haemoglobin and birth weight of the newborns.63
         Lund and Nhonoli et al found that the newborn of iron deficient
mothers had significantly lower levels of haemoglobin and iron in the
cord blood.64,65 Singla et al found that maternal haemoglobin had a linear
correlation with haemoglobin and iron levels in the cord blood.66 Fenton
et al  and Milman et al found that maternal ferritin correlated with cord
and newborn ferritin levels.67
         However  Cantwell  et  al  showed that  mothers  who were  given  less
than adequate iron therapy during pregnancy had babies with similar
cord-blood haemoglobin levels.68Turkay et al found no correlation
between maternal haemoglobin at 16 and 34 weeks gestation and
newborn haemoglobin parameters.69
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             Bhargava et al found maternal iron depletion did not adversely
affect newborn haemoglobin levels.70 Sturgeon demonstrated that fetal-
cord-bloodhaemoglobin levels were similar in anaemic and non-anaemic
mothers.71
           Rusia et al found that maternal haemoglobin did not correlate with
cord blood haemoglobin, but maternal haemoglobin were found to
correlate positively with cord ferritin.72
NEONATAL ANAEMIA
BACKGROUND
Haemoglobin levels increases with advancing gestational age: At
term, Cord blood hemoglobin is 16.8  g/dL (14-20 g/dL); hemoglobin
levels in very low birthweight (VLBW) infants are 1-2  g/dL less than
those in term infants.  Haemoglobin value less than the normal level of
haemoglobin for birthweight and postnatal age is defined as anemia.
Physiologic decrease in haemoglobin content is noticed at 8-12  wks in
term infants (haemoglobin, 11  g/dL) and at about 6 wk in premature
infants (7-10  g/dL).73
I. HEMATOLOGIC PHYSIOLOGY OF THE NEWBORN
Significant changes occur in the red blood cell (RBC) mass of an
infant during the neonatal period and ensuing months. The evaluation of
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anemia must take into account this developmental process, as well as the
infant’s physiologic needs.74
A. Normal development: The physiologic anemia of infancy
1.  In utero, the fetal aortic oxygen saturation is 45%, the
erythropoietin levels are high, and the RBC production is rapid.
The fetal liver is the major site of erythropoietin production
2. After birth, the oxygen saturation is 95%, and the erythropoietin is
undetectable. RBC production by day 7 is 1/10th the level in utero.
Reticulocyte counts are low, and the hemoglobin level falls .
3. Despite dropping haemoglobin levels, the ratio of haemoglobin A
to haemoglobin F increases and the levels of 2,3-
diphosphoglycerate (2,3-DPG) (which inter-acts with hemoglobin
A to decrease its affnity for oxygen, thereby  enhancing oxygen
release to the tissues) are high. As a result, oxygen delivery to the
tissues actually increases. This physiologic “anaemia” is not a
functional anaemia in that oxygen delivery to the tissues is
adequate. Iron from degraded RBCs is stored.75
4. At 8 to 12 weeks, hemoglobin levels reach their nadir, oxygen
delivery to the tissues is impaired, renal erythropoietin production
is stimu-lated, and RBC production increases.
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5.  Infants who have received transfusions in the neonatal period have
lower nadirs than normal because of their higher percentage of
hemoglobin A.76
6. During this period of active erythropoiesis, iron stores are rapidly
utilized. The reticuloendothelial system has adequate iron for 15 to
20 weeks in term infants. After this time, the hemoglobin level
decreases if iron is not  supplied.77
B. Anaemia of prematurity  is an exaggeration of the normal
physiologic anaemia.
1. RBC mass and iron stores are decreased because of low birth
weight; however, hemoglobin concentrations are similar in preterm
and term infants.
2. The hemoglobin nadir is reached earlier than in the term infant
because of the following:
a. RBC survival is decreased in comparison with the term
infant.
b. There is a relatively more rapid rate of growth in premature
babies than in term infants. For example, a premature infant
gaining 150 g/week requires approximately a 12 mL/week
increase in total blood volume.78
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c. Many preterm infants have reduced red cell mass and iron
stores because of iatrogenic phlebotomy for laboratory tests.
This has been somewhat amelio-rated with the use of
microtechniques.
d. Vitamin E deciency is common in small premature infants,
unless the vitamin is supplied exogenously
3. The hemoglobin nadir in premature babies is lower than in term
infants, because erythropoietin is produced by the term infant at a
hemoglobin level of 10 to 11 g/dLand is produced by the premature
infant at a hemoglobin level of 7 to 9 g/dL.
4. Iron administration before the age of 10 to 14 weeks does not
increase the nadir of the hemoglobin level or diminish its rate of
reduction. However, this iron is stored for later use.78
5. Once the nadir is reached, RBC production is stimulated, and iron
stores are rapidly depleted because less iron is stored in the
premature infant than in the term infant.
Causes of neonatal anaemia
1. Obstetric causes of blood loss, including the following malformations
of placenta and cord:
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a. Abruptio placentae
b. Placenta previa.
c.Incision of placenta at cesarean section
d. Rupture of anomalous vessels (e.g., vasa previa, velamentous insertion
of cord,
e. Hematoma of cord caused by varices or aneurysm.
f. Rupture of cord (more common in short cords )79
2. Occult blood loss:
a. Fetomaternal bleeding may be chronic or acute. It occurs in 8% of all
pregnancies;
The diagnosis of this problem is by Kleihauer-Betke stain of
maternal smear for fetal cells. Chronic fetal-to-maternal transfusion is
suggested by a reticulocyte count >10%.80
Many conditions may predispose to this type of bleeding
 i. Placental malformations—chorioangioma or choriocarcinoma
 ii. Obstetric procedures—traumatic amniocentesis, external cephalic
version, internal cephalic version, breech delivery.
 iii. Spontaneous fetomaternal bleeding
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b. Fetoplacental bleeding:
i. Chorioangioma or choriocarcinoma with placental hematoma
ii. Tight nuchal cord or occult cord prolapse.
c. Twin-to-twin transfusion
3. Bleeding in the neonatal period may be due to the following causes:80
a. Intracranial bleeding associated with:
 i. Prematurity
 ii. Second twin
iii. Breech delivery
iv. Rapid delivery
v. Hypoxia
b. Massive cephalhematoma, subgaleal hemorrhage.
c. Retroperitoneal bleeding.
d. Ruptured liver or spleen.
e. Adrenal or renal hemorrhage
f. Gastrointestinal bleeding (maternal blood swallowed from delivery or
breast should be ruled out by the Apt test) :
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i. Peptic ulcer ii. Necrotizing enterocolitis iii. Nasogastric catheter
g. Bleeding from umbilicus.
4. Iatrogenic causes. Excessive blood loss may result from blood
sampling with inadequate replacement.
B. Hemolysis
1. Immune hemolysis :
a. Rh incompatibility
b. ABO incompatibility
c. Minor blood group incompatibility (e.g., c, E, Kell, Duffy)
d. Maternal disease (e.g., lupus), autoimmune hemolytic disease,
rheumatoid arthritis (positive direct Coombs test in mother and newborn,
no antibody to common red cell antigen Rh, AB, etc.), or drugs.78
2. Hereditary RBC disorders:
a. RBC membrane defects such as spherocytosis, elliptocytosis, or
stomatocytosis.
b. Metabolic defects.
 Glucose-6-phosphate dehydrogenase (G6PD) deficiency ,
pyruvate  kinase deficiency,
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5' nucleotidase deficiency, and glucose-phosphate isomerase  deficiency.
c. Hemoglobinopathies :
i. ?- and ?-Thalassemia syndromes
ii. ? - and ? -Chain structural abnormalities.
3. Acquired hemolysis
a. Infection: bacterial or viral
b. Disseminated intravascular coagulation
c. Vitamin E deficiency and other nutritional anemias
d. Microangiopathic hemolytic anemia,
cavernous hemangioma, renal artery stenosis and severe coarctation of
the aorta
c. Diminished RBC production
Is manifested by a decreased Hct, decreased reticulocyte count, and
normal bilirubin level.76
1. Diamond-Blackfan syndrome
2. Congenital leukemia or other tumor
3. Infections, especially rubella and parvovirus
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4. Osteopetrosis, leading to inadequate erythropoiesis
5. Drug-induced suppression of RBC production
6. Physiologic anaemia or anaemia of prematurity79
PATHOPHYSIOLOGY OF NEONATAL ANAEMIA
Gradual and progressive decline in Hb concentration is noted in the
eight to ten weeks post natal age in the neonates.
        The decline of haemoglobin in term infants  reaches a nadir of
approximately 11 to 12 g/dL and is considered as early anemia. This is  a
normal  physiological  process  and  does  not   need   any  treatment.It  is  a
physiological condition  believed to be due to several factors. The most
important  factor  is increase in tissue oxygenation experience. There is a
switching from placental dependency to dependency on the lungs for
oxygen exchange.73
This transition occurs due to decreased  responsiveness to hypoxia
in fetus relative to adults. There is a lower  set point of tissue oxygenation
for  fetuses   compared  to   to  adults.  Other  factors  contributing  to  the
postnatal decrease in haemoglobin levels include  increased rate of body
growth, low blood erythropoietin (EPO) levels and shortened RBC
lifespan. The cause of the anemia can be identified by history and
physical examination.74
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Hemoglobin Changes in Babies in the First Year of Life117
Hemoglobin Nadir in Babies in the First Year of Life117
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CLASSIFICATION OF ANAEMIA IN THE NEWBORN
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CLINICAL FINDINGS
In case of mild anaemia,there may be no signs.With more severe
anemia, findings include:75
CLINICAL FEATURES OF ANAEMIA
? Pallor
? Tachycardia
? Tachypnoea
? Apnoea
? Increased oxygen requirements
? Lethargy
? Poor feeding
? Hepatosplenomegaly
? Jaundice
? Wide pulse pressure
? Hypotension
? Metabolic acidosis with severe anaemia
III. DIAGNOSTIC APPROACH TO ANAEMIA IN THE
NEWBORN
The family history should include questions about anemia,
jaundice, gallstones, and splenectomy.
B.  The obstetric history should be evaluated.
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C.  The physical examination may reveal an associated abnormality and
provide clues to the origin of the anemia.
1. Acute blood loss leads to shock, with cyanosis, poor
perfusion, and acidosis.
2. Chronic blood loss produces pallor, but the infant may
exhibit only mild symptoms of respiratory distress or
irritability.
3. Chronic hemolysis is associated with pallor, jaundice, and
hepatosplenomegaly.77
D. Complete blood cell count.
Capillary blood Hct is 2.7% to 3.9% higher than venous Hct.
Warming the foot reduced the difference from 3.9% to 1.9% .
E. Reticulocyte count
Elevated with chronic blood loss and hemolysis, depressed with
infection and production defect.
F. Blood smear
G. Coombs test and bilirubin level 78
H. Apt test   on gastrointestinal blood of uncertain origin.
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I. Kleihauer-Betke preparation  of the mother’s blood. A 50-mL loss of
fetal blood into the maternal circulation will show up as 1% fetal cells in
the maternal circulation.
J. Ultrasound of abdomen and head.
K. Parental testing. Complete blood cell count, smear, and RBC indices
are useful screening studies. Osmotic fragility testing and RBC enzyme
levels (e.g., G6PD, pyruvate kinase) may be helpful in selected cases.
L. Studies for infection. Toxoplasmosis, rubella, cytomegalovirus
(CMV), and herpes simplex
M. Bone marrow  examination  is rarely used, except in cases of bone
marrow failure from hypoplasia or tumor.79-80
MANAGEMENT OF NEONATAL ANAEMIA
Severity of anemia. should be assessed as the management dffers.
1. Prenatal causes : significant fetal anaemia occurs in hemolytic disease
and parvovirusB19, where as other conditions have mild anaemia.81
2. Postnatal:
A. Anaemia of prematurity:
The important methods   management are:
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•frequent blood samling for laboratory tests should be avoided
•Treatment with recombinant human erythropoietin should be considered
• packed red blood cells transfusion  (PRBCs) for severe anaemia.
In case of Severe anaemia: With severe, symptomatic anaemia, the
infant’s cardiovascular system may not be able to tolerate the increased
blood volume from simple transfusion of  packed red blood cells. In such
cases, performing a partial exchange transfusion with Packed red blood
cells (PRBCs) is done.82
Volume of PRBCs to exchange, use the following formula:
Volume of PRBCs = (Desired haematocrit – Patient’s Haematocrit)x
weight (kg) x 90 cc/kg
for exchange (cc) (PRBC Hct – Patient’s Hct)
Indications for transfusion
The decision to transfuse must be made in consideration of the
infant’s condition and physiologic needs.83
Transfusion with adult RBCs provides the added benefit of lowered
haemoglobin oxygen affinity, which augments oxygen delivery to tissues.
Blood should be fresh (3–7 days old) to ensure adequate 2,3-DPG levels.
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Isovolemic transfusion with high hematocrit (Hct)-packed RBCs
may be required for severely anemic infants, when routine transfusion of
the volume of packed RBCs necessary to correct the anemia would result
in circulatory overload .84
TRANSFUSION GUIDELINES
General Principles of packed red blood cells transfusion
RBCs provide oxygen carrying capacity for patients whose blood
lacks sufficient oxygen carrying capacity due to anemia, hemorrhage or
hemoglobinopathySeveral types of RBC units are available that vary in
the preservatives added.85-87
Chemical additives delay storage damage to RBCs allowing for
extended storage times. a. Anticoagulant-preservative solution units:
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These units contain approximately 250 mL of a concentrated
solution of RBCs. The average hematocrit of these units is 70% to 80%.
In addition, these units contain 62 mg of sodium, 222 mg of citrate, and
46 mg of phosphate.88
Three types of units are currently approved for use. These are
i. CPD. This contains 773 mg of dextrose and has a 21-day shelf life.
ii. CP2D. This contains 1,546 mg of dextrose and has a 21-day shelf life.
iii. CPDA-1. This contains 965 mg of dextrose and 8.2 mg of adenine and
has a 35-day shelf life. This is the most widely used of the anticoagulant
preservative solution units.
b. Additive solution units. Most RBC units used are additive units. Three
additive solutions are currently approved for use. Each of these units
contains approximately 350 mL, has an average hematocrit of 50% to
60%, and has a 42-day shelf life. 90
Several changes occur in Packed RBCs during storage:
a. The pH decreases from 7.4–7.55 to pH 6.5–6.6 at the time of
expiration.
b. Potassium is released from the RBC. The initial plasma K+
concentration is 4.2 mM and increases to 78.5 mM in CPDA-1 units at
64
day 35 and 45 to 50 mM in additive solution units on day 42. CPDA-1
units contain about one-third the plasma volume as additive units so the
total amount of extracellular potassium is similar in all units of the same
age.91
c. 2,3-diphosphoglycerol (2,3-DPG) levels drop rapidly during the first 2
weeks of storage. This increases the affinity of the hemoglobin for
oxygen and decreases its efficiency in delivering oxygen to tissue. The
2,3-DPG levels replenish over several hours after being transfused.
3. Toxicity.
Although there are theoretical concerns that mannitol may cause a
rapid diuresis and adenine may be a nephrotoxin in the premature infant,
case reports and case series have found no risk associated with additive
solution units. Hence, some hospitals transfuse additive solution units to
neonates. 92
Nonadditive solution units or washed additive solution units for
larger transfusions such as exchange transfusions are used.
Dosing and administration
The  dose  for  a  simple  transfusion  is  5  to  15  mL/kg  which  is
transfused at a rate of 5 mL/kg/hour. This may be adjusted depending on
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the severity of the anaemia and the patient’s ability to tolerate increase in
intra-vascular volume.
Side effects of transfusion of Packed red blood cells:
1. Acute transfusion reactions:
a. Acute hemolytic transfusion reactions.
These reactions are usually due to incompatibility of donor RBCs
with antibodies in the patient’s plasma. The antibodies usually
responsible for acute hemolytic transfusion reactions are iso-
hemagglutinins (anti-A, anti-B). These reactions are rare in neonates
because they do not make isohemagglutinins until they are 4 to 6 months
old. However, maternal isohemagglutinins can be present in the neonatal
circulation.92-93
 i. Symptoms. Possible symptoms include hypotension, fever,
tachycardia, infusion site pain, and hematuria.
ii. Treatment.
Administer fluids and furosemide to protect kidneys. If necessary,
treatment for hypotension with pressors and hemostatic agents for
bleeding are used. Transfusion with compatible Packed RBCs may be
needed.94
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b. Allergic transfusion reactions.
These are unusual in neonates. Allergic reactions are due to
antibodies  in  the  patient’s  plasma  that  react  with  proteins  in  donor
plasma.93
 i. Symptoms. Mild allergic reactions are characterized by hives and
possibly wheezing. More severe reactions can present such as
anaphylaxis.
ii. Treatment. These reactions can be treated with antihistamines,
bronchodilators and corticosteroids as needed. These reactions are usually
specific to individual donors. If they are serious, RBCs and platelets can
be washed.94
c. Volume overload.
Blood components have high oncotic pressure and rapid infusion
can cause excessive intravascular volume. This can cause a sudden
deterioration of vital signs. Chronically anemic neonates can be
especially susceptible to volume overload from transfusions.95
d. Hypocalcemia.
Rapid infusion of components especially Fresh frozen plasma, can
cause transient hypocalcemia.
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e. Hypothermia. Cool blood can cause hypothermia. Transfusion
through blood warmers can prevent this.
f. Transfusion-associated acute lung injury (TRALI).
This is often due to antibodies in donor plasma that react with the
patient’s histocompatibility (HLA) antigens. These reactions present as
respiratory compromise and are more likely to occur with blood
components containing significant amounts of plasma such as platelets or
FFP.96
g. Hyperkalemia.
Extracellular potassium dosage is not significant for simple
transfusions of 5 to 20 mL/kg. However, hyperkalemia can be important
in large transfusions such as exchange transfusions or transfusions for
major surgery. Ideally, fresher PRBC units can be provided for these
transfusions. If fresh RBCs are unavailable, washing blood will
temporarily reduce the extracellular potassium.96
h. Febrile Nonhemolytic transfusion reactions
These reactions are usually due to cytokines released from
leukocytes  in  the  donor  unit.  These  occur  less  frequently  if  the  unit  is
leukoreduced.
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i. Bacterial contamination can  occur  but  is  relatively  rare  with  RBC
transfusions.
j. Transfusion-associated graft-versus-host disease (TA-GVHD).
Lymphocytes from donor blood components can mount an immune
response  against  the  patient.  Patients  are  at  risk  if  they  are  unable  to
mount immune responses against the transfused lymphocytes. Such
patients include premature infants, infants with congenital immune
deficienciesTransfusion associated-GVHD can be prevented by
irradiation.97
B. Prophylaxis
1. Term infants should be sent home from the hospital on iron-
fortified formula (2 mg/kg/day) if they are not breastfeeding .
2. Premature infants (preventing or ameliorating the anemia of
prematurity)
Iron supplementation in the preterm infant prevents late iron
deficiency. Supplementation of  iron in premature infants at a dose of 2 to
4 mg of elemental iron/kg/day can be given once full enteral feeding is
achieved
69
Vitamin E (15 to 25 IU of water-soluble form) is given daily upto
38 to 40 weeks  postconceptional age.This is usually stopped at discharge
from the hospitalThese infants should be followed up carefully and
additional iron supplementation may be required.98
Recombinant human erythropoietin (rh-EPO) has been evaluated as
a promising measure in ameliorating anemia of prematurity. Studies have
shown  that  rh-EPO  stimulates  RBC  production  and  decreases  the
frequency and volume of RBC transfusions administered to premature
infants. 98
UMBILICAL CORD BLOOD
History of  Umbilical Cord Blood
? First successful related cord blood transplant conducted in France,
on a six-year-old male patient suffering from Fanconi's Anemia
done in 1988.
? First public bank for umbilical cord blood established in 1992 by
Dr.Pablo at New York blood center.
? First unrelated cord blood transplant in the world is performed in
1993  by Dr. Joanne Kurtzberg  at Duke University's Pediatric
Blood and Marrow Program.99
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? National Marrow Donor Program (NMDP) launched cord blood
program in 1998
? The Stem Cell Research and Therapeutic Act of 2005, to create  a
national inventory of 150,000 diverse, high-quality cord blood
samples done in 2005.
? Over 30,000 unrelated cord blood transplants performed in 2012.100
UMBILICAL CORD
The umbilical cord contains two umbilical arteries and one
umbilical vein. Umbilical vessels are surrounded by connective tissue
known as "Wharton's jelly". Length of the cord less than 35 cm is called
as  short  cord  and  the  length  of  the  cord   measuring  more  than  80  cm is
considered as long cord .The average  umbilical cord circumference is 3.6
cm  at  40  weeks.   In  a  term  baby,  area  of  the  umbilical  cord   is  1.3  cm
square.101
The length of the cord is an important parameter that affects the
foetal activity. It is dependent on the tension caused by the freely moving
foetus, mainly during the second trimester. The short cord is associated
with decreased foetal activity. short cord may also be associated with
maldevelopment of the central nervous system.102 Certain developmental
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abnormalities including Down syndrome .may be associated with short
cord.
Fetal metabolic condition can be determined by the umbilical cord
gas sampling at  the moment of  birth.  Both arterial  and venous umbilical
cord blood samples for analysis are preferred.103
Equipment Required for cord blood sampling:104
?Gloves
?Heparinised syringes x 2
?Needles 21g x 2
?Face shield
?5 clamps
?Optional (ice and water)
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METHOD  OF CORD BLOOD COLLECTION
Instructions for Collection of cord blood Prior to Expulsion of
Placenta:
Double clamping of the umbilical cord is done after delivery of the infant
and also prior  to expulsion of the placenta.
Proposed needle insertion site of the cord is sterilised with the antiseptic
prep pad.
Needle insertion site should be just above the clamp that remains on the
cord.
Insertion of the needle of Collection Bag is done into the cord.
Collection of the blood is done as much as possible via gravity-flow,
aiming to fill a minimum of 80 mL.
Cord will appear empty and pale when collection is completed.
Two tight knots are done in the tubing as close to the needle as possible.
Gentle rotation of the bag several times to thoroughly mix the cord blood
with the anticoagulant is finally done.105
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Instructions for Collection of cord blood following Expulsion of
Placenta or After Caesarean Delivery:
Double-clamping and cutting of the umbilical cord is being done.
Placenta and umbilical cord is placed in a sterile tray in such a way that
fetal side is down.
The placenta is placed on an elevated surface and umbilical cord is
draped out of the tray.
Proposed needle insertion site of the cord is sterilised with the antiseptic
prep pad
Needle insertion site should be just above the clamp that remains  on the
cord.
Collection of the blood is done as much as possible via gravity-flow,
aiming to fill a minimum of 80 mL.
Two tight knots are done in the tubing as close to the needle as possible.
Gentle rotation of the bag several times to thoroughly mix the cord blood
with the anticoagulant is finally done.106
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Procedure for labelling Cord Blood Sample :
? Collection  Kit  case  ID  is  affixed  to  the  Collection  Bag  and  the
Collection Bag is placed into Specimen Transport Bag. A cord blood
sample in a heparinised syringe is stable for up to 60 minutes at room
temperature.107
? The Collection Form is then filled
? Blood samples are labelled with Unique Number of mothers as the
results are part of the maternal obstetric history.
CORD BLOOD USES
Umbilical  cord  blood  was  not  stored  before  till  the  discovery  of
stem cells in the cord blood. Now  cord blood of  neonates are stored in
the cord blood banks. There is no risk in collecting cord blood and it is
safely preserved in the cord blood bank.Cord blood contains stem cells
and these cells are haematopoietic stem cells capable of differentiating
into cells of any organ.108
            Since 1989, cord blood is being used to treat children with blood
diseases and also in research used to treat adult patients.  Cord blood cells
has capacity to grow and they can develop into various types of cells
throughout the body. They can be harvested after birth and stored for
75
future transplantation in patients with blood disorders and also in many
types of cancer.
Haematopoietic stem cells (HSCs) are maintaining blood
production throughout our lives since they can make every type of cell in
the blood like RBC,WBCs and platelets.Cord blood is being used for
years in bone marrow transplants for treating blood diseases.109 Umbilical
cord blood used as Hematopoietic Stem Cell Transplantation (HSCT)
source for conditions transplanted with  Peripheral Blood Progenitor Cell
(PBPC).
Stem cells of the cord blood can produce specialised cells such as
nerve cells. cord blood samples are used to  treat children with cancerous
blood disorders and also genetic blood diseases like Fanconi anaemia.110
These include:
UMBILICAL CORD BLOOD USES IN DISEASES
? Hematological and Other Malignancies
Leukemias:
Chronic myelogenous leukemia(CML)
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Acute myelogenous leukemia    (AML)
Acute lymphoblastic leukemia   (ALL)
Chronic lymphoblastic leukemia  (CLL)
Lymphoma:
Hodgkin's disease
Non hodgkin's lymphoma
Histiocytosis X
Auto immune lympho proliferative disease
Myelodysplastic syndrome(MDS)
Myelo fibrosis
? Immune deficiencies
? Bone Marrow Failure Diseases
? Platelet Diseases:
    Congenital thrombocytopenia
     Glanzmann's thrombasthenia
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Haemoglobinopathies
? Sickle Cell Disorders
? Thalassemia Disorders
Metabolic/ Storage disorders
? Hurler's disease
? Morquio syndrome
? Amyloidosis
? Gaucher's disease
? Krabbe's disease
? Niemann pick disease
? Lesch-Nyhan Syndrome
? Metachromatic Leukodystrophy
Red Blood Cell Diseases
White Blood Cell Diseases:
? Chronic granulomatous disease(CGD)
? Chediak Higashi syndrome
? Severe Combined Immune Deficiency (SCID)
? Wiskott-Aldrich Syndrome
? X-linked Hyper-IgM Syndrome
? X-linked Immune Dysregulation
Inherited Transfusion Dependent Anemias111
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             Cord blood is being transplanted into the patient, where the
hematopoietic stem cells  make  new healthy blood cells to replace those
damaged by  medical treatment such as cancer chemotherapy.110
          Cord blood offers alternative for bone marrow transplants for few
patients. It can be stored frozen till it is needed. Umbilical cord blood is
less likely than bone marrow to cause immune rejection such as Graft
versus Host Disease than bone marrow. This means that cord blood  need
not to be perfectly matched as bone marrow to the patient.112
          Stem cells derived from cord blood has therapeutic potential for
neuroregeneration and also for improved functional outcome. Cord blood
also finds its use in treatment of hypoxic brain injury.
Likely mechanism
Participation in blood vessel regeneration, suppression of the
release of inflammatory cells from the spleen, improvement of survival of
intrinsic cells via neurotropic factors.
Most important issue being timing of  administration of cord blood
with respect to  time of  injury:  earlier the better.113
Umbilical cord blood transplants have some limitations. Two units
of cord blood is needed for treatment of one adult. Many studies has
shown cord blood uses to treat blood diseases only. For non-blood-related
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diseases no therapies have been developed using hematopoietic cells from
cord blood.
Several phase1 and phase 2 studies are in progress in evaluating the
use of cord stem cells in the treatment of cerebral palsy,Type I diabetes,
in traumatic brain injury and in neonatal encephalopathy.
These are the following tests performed on the cord blood:
? Complete blood count:  CBC is an important paerameter to know
the evidence of  infection.
? Platelet count: Measure of  blood's clotting ability
? Blood type: blood grouping typing
? Blood cultures : To test for aerobic and anaerobic bacteria ,in order
to rule out infection.
? Positive blood culture may be useful in detecting  abnormal
bacteria in the mother or infant.
? Cord blood pH (acid level)-useful indicator of acidosis and this is
useful in the diagnosis of  perinatal hypoxia.112
? Low pH (< 7.25) indicates  acidosis in the infant's bloodstream.
Acidosis occurs if mother or baby does not get enough oxygen
during delivery.
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? Blood gas analysis : in order to evaluate the levels of oxygen and
carbon dioxide levels in newborns.113
CORD BLOOD BANKING:
Prospective parents may seek information regarding umbilical cord
blood  banking. Balanced and accurate information regarding the
advantages and disadvantages of public versus private banking should be
provided. 114
Health care providers should dispense the following information
1. There is clinical potential of hematopoietic stem cells found in cord
blood.
2. Where logistically possible, collection and support of umbilical
cord blood for public banking is encouraged.
3.  The indications for autologous (self) transplantation are limited.
4. Private cord blood banking should be encouraged when there is
knowledge  of  a  family  member,  particularly  a  full  sibling,  with  a
current or potential medical condition (malignant or genetic) that
could potentially benefit from cord blood transplantation.
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5. Storing cord blood as “biologic insurance” should be discouraged
because there is currently no scientific data to support autologous
transplantation.115
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MATERIALS AND METHODS
This  study  is  a  cross  sectional  type  of  study  done  at  Govt.kilpauk
medical college and hospital in the Department of paediatrics. The study
protocol was approved by Ethical committee for research studies of
kilpauk medical college and hospital.
Study design:
Cross sectional study
Study period :
6 months (March 2016-August 2016)
Study population:
Pregnant mothers attending the labour room in kilpauk medical
college hospital and their babies delivered were included in the study.
Sample size:
400 pregnant mothers attending the labour room in kilpauk medical
college and their babies delivered were included in this study.Sample size
was calculated depending upon the prevalence of anaemia in antenatal
mothers in previous studies by using the formula 4p/L^2.prevalance of
anaemia in the previous  study was around 50%.
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INCLUSION CRITERIA
? Fullterm neonates [37-41weeks]
? Preterm neonates  > 34 weeks
? Women with singleton pregnancies
? Primi/multiparity
? Babies born to normal vaginal deliveries/caesarean section
? Babies born with birth weight of 2-4 kg
EXCLUSION CRITERIA:
? Newborns with congenital malformations
? Birth asphyxia
? Twins
? Rh incompatability
? Maternal risk factors like Gestational diabetes mellitus,Pregnancy
induced hypertension, placenta praevia and abruptio placenta.
METHODOLOGY:
400 pregnant mothers attending the labour room in kilpauk medical
college  and  their  babies  delivered  were  included  in  this  study.  After  the
delivery of the  baby, cord blood haemoglobin was collected.  Double
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clamping of the umbilical cord is done after delivery of the infant and
also prior  to expulsion of the placenta.Umbilical vein was identified and
the needle insertion site  was sterlised with antiseptic preparation pad.
Cord blood sample was collected from the placental end of severed cord.
About 2 ml of blood was aspirated from the umbilical vein using a sterile
syringe and blood was transferred to a test tube containing
EDTA.Collected blood samples were analysed in the pathology lab in
automated analyser for haemoglobin estimation.
Predelivery  maternal haemoglobin  was  estimated. Both  cord
blood and the maternal haemoglobin  were determined.   Based on the
maternal haemoglobin values  mothers were  classified  in to two
groups,namely anaemic  and  non anaemic. Those mothers  with
haemogobin values  less than 11g/dl were considered as anaemic and
those mothers with haemoglobin  more than 11g/dl were considered as
non anaemic. Anaemic mothers with  haemoglobin less  than 11g/dl were
classified into 3 groups,namely  mild ,moderate and severe anaemia.
Cord blood haemoglobin values of  anaemic and non anaemic
group  was compared. Among the anaemic mothers the mean cord blood
haemoglobin in the three groups (mild, moderate, severe) were
determined. The mean cord blood haemoglobin of each group was
compared with the mean cord blood haemoglobin of the neonates born to
the  non anaemic mothers.
85
STATISTICAL ANALYSIS
Statistical  analysis  was  performed  using  SPSS  21.  Student  t  test
was used to determine whether there was any significant difference
between the two groups.
 P value of lessthan 0.05 was taken as  significant.
AUTOMATED ANALYSER
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CORD BLOOD COLLECTION
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RESULTS
TABLE SHOWING  NUMBER AND PERCENTAGE OF
ANAEMIC AND NON ANAEMIC MOTHERS
GROUP Number of
subjects
Percentage of
subjects
(%)
Anaemic mothers 192 48
Non anaemic mothers
208
52
PIE CHART SHOWING NUMBER OF ANAEMIC AND NON
ANAEMIC MOTHERS
48 % of anaemic mothers and 52% of non anaemic mothers were
included in our study.
48%(192)
52%(208)
Anaemic
Non anaemic
88
TABLE SHOWING NUMBER OF ANAEMIC MOTHERS  BASED
ON ITS SEVERITY
Classification No of anaemic
mothers
Percentage(%)
Mild- 10-10.9 gm/dl                94              48.9
Moderate- 9.9-7 gm/dl                 82                42.8
Severe- <7 gm/dl                  16                 8.3
Showing categorisation of anaemic mothers based on its severity:
BAR DIAGRAM SHOWING NUMBER OF ANAEMIC MOTHERS
BASED ON ITS SEVERITY
0
10
20
30
40
50
60
70
80
90
100
10-10.9 9.9-7 <7
No of patients
Severity of anaemia
No of patients
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TABLE SHOWING NUMBER AND PERCENTAGE OF PRE
TERM AND TERM BABIES:
Gestation Number of babies Percentage of babies
 Pre term babies                 52              13
 Term babies               348              87
PIE CHART SHOWING NUMBER OF PRE TERM AND TERM
BABIES
13%(52)
87%(348)
preterm
term
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TABLE SHOWING NUMBER AND PERCENTAGE OF
ANAEMIC MOTHERS BASED ON THEIR RURAL /URBAN
AREA
Rural/urban
area
Number of anaemic
mothers
Percentage of
anaemic mothers
(%)
      Rural            122             63.6
      Urban             70             36.4
PIE CHART SHOWING NUMBER OF ANAEMIC MOTHERS
BASED ON THEIR RURAL  / URBAN AREA
63.6%(122)
36.4%(70)
Rural
Urban
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TABLE SHOWING MEAN AGE,MEAN MATERNAL
HAEMOGLOBIN AND MEAN CORD HAEMOGLOBIN AMONG
ANAEMIC AND NON ANAEMIC MOTHERS
Group Mean age Mean
maternal
haemoglobin
Mean cord
haemoglobin
P value
Anaemic
mothers
25.79±2.22 9.38±1.08 15.03±1.04 P<0.05
Non
anaemic
mothers
25.72± 2.46 11.78 ± 0.52 16.37 ± 0.85
Mean cord haemoglobin between anaemic and non anaemic
mothers were compared and the difference between them was statistically
significant with p<0.05
TABLE SHOWING  MEAN HAEMOGLOBIN IN ANAEMIC
MOTHERS BASED ON THE SEVERITY OF ANAEMIA
Maternal
haemoglobin
Mean haemoglobin
gm/dl
No. of patients
10-10.9 gm/dl 10.43±0.23 94
9.9-7gm/dl 9.03±0.85 82
<7gm/dl 6.6 ±0.31 16
92
TABLE SHOWING MEAN MATERNAL AND CORD BLOOD
HAEMOGLOBIN
Maternal
Haemoglobin
Mean
haemoglobin
gm/dl
No. of
patients
Mean
Cord blood
hamoglobin
gm/dl
P value
10-10.9 gm/dl 10.43±0.23 94 15.54±0.77 P<0.05
9.9-7gm/dl 9.03±0.85 82 14.7±0.93 P<0.01
<7gm/dl 6.6 ±0.31 16 14.08±0.88 P<0.05
The mean cord hemoglobin among the three groups (mild
moderate  severe) were compared with mean cord hemoglobin of the non
anaemic group. The difference between the groups were statistically
significant with P values <0.05,0.01 and 0.05 respectively.
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DISCUSSION
       In our study we compared the maternal haemoglobin with cord
haemoglobin in order to find whether there is any  relationship between
the two parameters. We enrolled 400 mothers in the study and their
predelivery haemoglobin level was determined. Out of 400 mothers,192
mothers had haemoglobin less than 11g/dl and 208 mothers had
haemoglobin more than 11g/dl. Among the anaemic mothers  94 had mild
anaemia (haemoglobin between  10-10.9g/dl). 82 mothers had moderate
anaemia(haemoglobin between  7-9.9g/dl).16 mothers had severe
anaemia with  haemoglobin less than 7g/dl.
We observed about 48% of the mothers were anaemic and 52%
were non anaemic. Among the anaemic mothers 48.9% of them had mild
anaemia, 42.8% of them  had moderate anaemia and 8.3% of them had
severe anaemia.
Among the 400 babies delivered  348 were term babies(87%) and
52 were preterm babies(13%).we observed  that among the 192 anaemic
mothers , 122 of them were from rural area which accounts to about
63.6% and 70 of them were from urban area which accounts to about
36.4%.
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We  found  that   mean  age  of  anaemic  mothers   were   25.79±  2.22
and mean age of  non anemic mothers were 25.72±2.46. The  mean
maternal haemoglobin  among non anaemic mothers were 11.78 ± 0.52
and among the  anaemic mothers was found to be 9.38±1.08.
The   mean  cord  haemoglobin   among   non  anaemic  mothers  was
16.37 ± 0.85 and among the anemic mothers it was 15.03±1.04. The
mean maternal haemoglobin  in mothers with mild anaemia was 10.43±
0.23 and the mean haemoglobin in mothers with moderate  anaemia was
9.03± 0.85 and the mean haemoglobin in mothers with severe anaemia
was 6.6 ± 0.23.
The mean cord hemoglobin  among the three groups (mild,
moderate, severe) was 15.54± 0.77,14.7± 0.93 and 14.08± 0.88
respectively. The mean cord hemoglobin  between the anaemic and non
anemic group  was compared and the difference between  the two groups
was statistically significant with p value < 0.05.
The mean cord hemoglobin among the three groups(mild  moderate
severe) were compared with mean cord hemoglobin of the non anaemic
group  and the difference  was statistically significant  with  P value less
than 0.05,0.01 and 0.05  respectively.
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On comparing the cord haemoglobin  with maternal haemoglobin
we  found   that  there  was  a  linear  relationship  between  the   two
parameters. It was  observed  as that as mean   maternal haemoglobin
decreases, there was a decrease in the cord haemoglobin. This denotes
that there  is an impact of maternal anaemia on cord haemoglobin. This
observation  was  similar  to  the  study  done  by  Nadia  et  al  in   babylon
university which showed a linear relationship between maternal
haemoglobin and cord haemoglobin.
Debbarmarubi et al  also showed a linear  relationship  between the
cord and maternal haemoglobin  similar to our study. Marmoury GH et al
study  differs   from  our  study  as  they  reported  that  there   was  no
association  between  cord haemoglobin  and maternal  haemoglobin
levels.63
In our study  we found that mothers with anaemia were more likely
to deliver babies with lower hemoglobin levels.This  observtion  made  us
to rethink the belief  that fetus continues to extract iron from the mother
regardless of her iron status. Sweet et al in their study had shown that
mothers with iron deficiency anaemia  gave birth to newborn with lower
hemoglobin  level.Previous studies also suggest that iron supply to the
placenta and the fetus is affected in maternal anaemia and the fetus takes
iron in direct proportion to the levels  available in the mother.
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Terefe  B  et  al  in  their  study  titled  "Effect  of  Maternal  Iron
Deficiency Anemia on the Iron Store of Newborns "enrolled 21 anaemic
mothers and 78 non anaemic mothers and found that lower level of
ferritin in newborns delivered from Iron deficiency anaemia (IDA)
mothers compared to non anaemic mothers suggests reduced iron stores
in these newborns. And also found that newborns delivered from IDA
mothers had a significantly lower concentration of hemoglobin than
newborns from non anaemic mother, which is correlating with the results
of our study.
Iron is actively transported from mother to fetus. In order to ensure
an adequate iron supply to the growing  fetus even in the anaemic mother,
there is up regulation of iron transport proteins in the placenta in the iron
deficiency state.Our study also demonstrated that the cord haemoglobin is
lower in anaemic mothers and that the decrease in cord haemoglobin
appears to be proportional to the degree of anaemia. This suggests that
placental iron transport mechanisms may not work at higher degrees of
anaemia and thereby it leads to a fall in cord haemoglobin.
There are some limitations in our study, iron status of the mother
was not determined  and maternal haemoglobin level was not determined
in  the  first  and  second  trimester.  However,  it  is  likely  that  mothers  who
were anaemic in the third trimester had poor iron intake throughout  their
pregnancy and this may lead to decreased cord haemoglobin level.
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CONCLUSION
In our study we observed that maternal anaemia affects the cord
haemoglobin of  neonates. Our study infers that anaemic mothers deliver
babies with lower haemoglobin compared to non anaemic mothers. We
have found a linear relationship between maternal haemoglobin and  cord
blood haemoglobin  of the newborns.Anaemia during pregnancy  is a
commmon  complication  that can be detected by simple screening test.
Anaemia can lead to complications in both mother and foetus.
In developing countries like India, prophylaxis during pregnancy
can prevent anaemia and this may decrease the incidence of foetal and
maternal complications.
Overall neonatal survival outcome may also be increased. Further
studies are needed to determine the relation of iron stores of the mother
to the fetal iron and ferritin levels.
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Sl.N
O Name Age   Weight   Height     BMI Gravida/ Rural/
Materna
l Gestation     Birth cord blood
yrs kg cm kg/m2 para urban
Hb
(gm/dl)
weight(kg
) Hb (gm/dl)
1 b/o malliga 24 66 158 26.43 g2p1 rural 8.6 term 2.6 14.2
2 b/o  kanaga 26 75 160 29.33 primi urban 10.8 term 2.5 16.8
3 b/o sangeetha 27 73 159 29.24 primi urban 7.2 term 2.9 13.6
4 devi 24 76 162 28.95 g2p1 urban 12.2 term 3.1 17.1
5 srilakshmi 28 68 165 24.97 g3p1 rural 11.4 term 2.63 15.4
6 b/o priya 22 75 157 30.42 g2p1 urban 9.8 term 2.76 14.9
7 b/o geetha 25 76 154 31.62 primi urban 10.6 preterm 2.24 15.4
8 b/o deepa 28 65 149 29.27 primi rural 10.3 term 3.1 14.6
9 b/o harini 26 68 152 29.43 primi rural 11.2 term 3.3 16.4
10 b/o sujatha 27 72 160 28.12 primi rural 11.6 term 2.6 15.6
11 b/o kavitha 30 75 162 28.57 g3p1 rural 11.4 term 2.8 16.2
12 b/oradha 27 74 160 28.19 g2p1 urban 11.1 term 2.9 15.8
13 b/o kumari 23 68 163 25.91 primi rural 10.7 term 2.6 16.1
14 b/osankari 28 72 159 28.48 primi urban 9.6 term 2.2 14.6
15 b/oammu 26 78 158 30.85 g3p1 rural 10.1 term 2.5 15.3
16 b/0 sundari 28 65 145 30.91 primi rural 10.2 term 3.1 15.6
17
b/o
muthulakshmi 23 62 156 25.47 primi urban 8.6 term 2.8 13.1
18 b/o aiswarya 25 61 150 27.55 g2p1 rural 7.8
PRETER
M 2.18 13.9
19 b/o vasugi 28 65 152 28.13 g2p1 rural 11.8 term 3.4 16.8
20 durga 24 74 160 28.9 primi urban 9.6 term 3.3 17.2
21 mobeen 26 75 158 29.64 g2p1 urban 7.8 preterm 2.12 17.6
113
22 b/o christina 27 68 154 28.67 g2p1 rural 11.8 term 2.5 15.4
23 b/o rajamma 29 64 156 26.29 g2p1 urban 11.6 term 2.5 16.2
24 b/o kamala 23 74 160 28.9 primi rural 12.1 term 2.7 17.8
25 b/o vaishnavi 30 73 165 26.81 primi rural 11 term 2.9 16
26 b/o aarthi 32 65 156 28.65 g2p1 urban 9.2 term 3.2 14.7
27 b/o maragatham 26 61 159 24.12 g291 rural 10.4 term 3.5 14.8
28 b/o suseela 25 70 148 31.95 g2p1 rural 7.8 term 2.8 16.5
29 b/o rajeswari 27 60 160 23.43 g3p1 urban 10.2 preterm 2.1 13.9
30 b/o varsha 28 73 164 27.14 primi urban 6.2 term 2.6 13.4
31 b/o kalyani 31 76 166 27.58 primi rural 10.8 term 2.1 15.4
32 b/o ramya 29 74 158 29.64 g2p1 deepa 11.8 term 3.23 16.5
33 b/o ananthi 25 72 159 29.32 g2p2 urban 9.9 term 2.55 15
34 b/o fathima .m 27 70 163 26.34 primi urban 11.5 term 2.65 16.8
35 b/o  adhilakshmi 25 69 158 27.64 primi rural 11.2 term 2.76 15.1
36 b/o savithri 30 72 154 30.35 primi rural 10.1 term 2.8 14.6
37 b/o divya 28 75 153 32.03 g2p1 urban 6.6 term 2.9 15.1
38 b/o vani 27 68 150 30.22 g3p2 urban 10.4 term 2.6 15.1
39 b/o sridivya 26 69 156 28.35 g2p1 urban 12.1 term 2.7 15.4
40 b/o lalitha 23 66 154 27.83 g2p1 rural 7.6 term 2.7 16.4
41 b/o ramadevi 26 68 156 27.94 primi rural 9.1 term 2.8 16.2
42 b/o  tulasi 27 72 160 28.12 primi urban 11.8 preterm 2.2 15.8
43 b/o rani 28 75 154 31.62 g3p2 urban 11.1 term 2.7 15.6
44
b/o
dhanalakshmi 29 71 152 31.13 g2p1 rural 9.9 term 2.8 15.4
45 b/o indra 23 65 160 25.39 primi urban 10.3 term 2.5 15.3
46 b/o nirmala 25 63 148 28.76 g2p1 rural 11.8 term 2.9 15.1
47 b/o leela 26 73 153 31.18 g2p1 rural 10.2 term 3.1 15.6
48 b/o vidya 30 67 154 28.25 primi rural 9.8 preterm 2.2 15.5
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49 b/o kanimozhi 28 72 157 29.21 primi urban 11.1 term 2.56 16
50 b/o kamala 26 65 158 26.03 G3P2 rural 10.1 term 3.01 15.8
51 b/o  uma 24 72 152 31.2 g2p1 rural 10.4 term 2.9 16
52 b/o banu 23 71 149 32 g2p1 urban 9.6 term 3.1 16.2
53 b/o  dharani 25 68 152 29.4 primi urban 9.8 term 2.9 15.8
54 b/o elavarasi 26 74 160 28.9 primi urban 10.2 term 3.2 15.4
55  b/o harshini 24 65 151 28.5 g2p1 rural 11.4 preterm 2.1 16.1
56 b/o rohini 26 68 153 28.6 g2p1 urban 12.1 term 3.3 17.2
57 b/o vijaya 27 72 156 29.2 primi urban 11.6 term 3.2 16.2
58 b/o yogeswari 28 71 158 29.1 primi rural 11.7 term 3.1 16.8
59 b/o parameswari 24 65 152 28.1 primi urban 12.6 term 2.6 17.4
60 b/o fathima 30 74 159 29.3 g3p2 urban 11.5 term 3.3 15.7
61 b/o oviya 24 72 163 27.5 primi urban 11.7 term 3.2 16.1
62 rukmani 26 74 162 27.4 primi urban 10.8 preterm 2.1 15.1
63 b/okirthika 24 72 156 29.6 g2p1 rural 12.6 term 2.4 17.4
64 b/o indhumathy 22 65 156 26.7 primi rural 9.3 term 2.54 14.8
65 b/o sumathi 31 76 154 32 g2p1 urban 11.5 term 2.69 15.2
66 b/o roja 30 73 162 27.8 g3p2 urban 11.6 term 2.8 15.4
67 b/o latha 28 71 158 29.2 primi urban 11.2 term 3.1 14.8
68 b/o revathi 24 74 165 26.8 primi rural 10.6 term 2.5 15
69 b/o saraswathi 25 68 167 24.4 g2p1 urban 12.4 term 2.6 16.2
70 b/o krishnaveni 23 64 148 31 primi urban 11.5 term 2.456 15.4
71 b/o nancy 26 66 163 24.8 g2p1 rural 10.3 term 2.35 15.3
72 b/o urmila 22 71 159 28.1 primi urban 11.1 term 2.56 15.4
73 b/o suguna 27 58 146 26.5 g2p1 urban 12.1 term 3.32 17.4
74 b/o BRINDA 26 72 154 31.2 primi urban 9.3 term 3.4 15.1
75 b/o isaiyoli 31 67 158 26.8 g3p2 urban 11.8 term 3.09 16.2
77 b/o soundaruj 23 63 165 24.6 primi rural 11.2 term 2.582 15.6
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78 b/osrilakshmi 24 67 158 26.8 g2p1 urban 11.4 term 3.2 16
79 b/o karthika 25 64 165 23.5 g2p1 rural 10.6 preterm 2.1 15.8
80 b/o devi 24 73 160 28.5 primi urban 11.5 term 2.4 16
81  b/o harshini 26 75 157 29.6 primi urban 11.2 term 3.2 16.4
82 laila 27 68 158 27.6 primi rural 9.9 term 3.3 14.9
83 b/o shalini 22 76 153 32.5 g2p1 urban 12 term 2.9 17.1
84 b/o surekha 28 73 162 29 primi urban 11.1 term 2.6 15.1
85 b/o deepa 22 69 149 31.1 primi urban 11.8 term 3.1 15.4
86 b/o vanitha 28 65 158 26 g2p1 urban 11.4 term 2.11 16
87 b/o indra 25 73 160 28.5 primi urban 11.2 term 3.1 15.3
88 b/o stella 24 71 161 27.7 primi rural 10.5 preterm 2.1 14.9
89 b/o mala 28 64 165 24.2 primi urban 11.4 term 2.8 15
90 b/o nirmala 26 72 160 26.8 g2p1 urban 6.6 term 2.5 13.4
91 b/o chitra 24 75 154 30.4 g2p1 urban 11.1 preterm 2.11 15.4
92  b/o jeeva 26 72 157 29.2 primi urban 12.3 term 2.7 16
93 b/o dhanam 30 66 152 26.8 g3p2 rural 7.4 term 2.5 14.2
94 b/o ragini 25 68 160 25.8 primi urban 11.6 term 3.1 14.7
95 b/o revathy 27 62 148 31 g2p1 urban 12.2 term 2.75 16.8
96 b/o sundari 26 72 157 29.2 primi urban 11.1 term 2.58 16.2
97 b/o rathy 24 65 153 27.8 primi urban 11.2 term 2.5 15
98 b/o geethanjali 25 69 160 27 primi urban 11.6 term 2.8 16.4
99 b/o rasiga 23 72 159 28.1 primi rural 11.2 term 2.53 15.8
100 b/o aarth priya 25 75 165 26.4 g2p1 urban 11.4 term 2.54 16
101 b/o nisha 24 71 162 27.4 primi rural 12.5 term 2.53 17.6
102 b/o lavanya 26 65 159 25.7 g2p1 urban 10.5
PRETER
M 2.1 15.6
103
b/o
mahalakshmi 28 68 156 27.9 g2p1 urban 9.4 term 2.52 13.7
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104 b/o chandra 21 62 158 24.8 primi rural 9.9 term 2.65 14.8
105 b/o bargavi 24 74 161 28.5 g2p1 urban 11.3 term 2.54 15.8
106 b/o manjula 28 68 153 33.3 g3p1 urban 12.1 term 2.8 16.3
107 b/o kirthika 23 73 148 31.3 primi rural 11.4 term 3.12 16.2
108 b/o latha 30 59 162 22.5 g2p1 urban 11.3
PRETER
M 2.18 15.8
109 b/o janani 24 62 149 27.9 primi urban 12.2 term 3.1 15.6
110 b/o meenakshi 26 68 158 27.2 g2p1 urban 11.4 term 2.45 16.4
111 b/o gandhimathi 25 67 161 21.9 primi rural 10.2 term 2.56 15.2
112 b/o padmini 27 69 158 27.6 g2p1 urban 10.1 term 2.84 15
113
b/o
govindammal 24 72 152 31.2 primi rural 11.5 term 2.35 16.5
114 b/o nithya 25 74 156 30.4 g2p1 urban 9.5 term 2.47 15.4
115 b/o vasugi 28 76 163 32.5 g2p1 rural 10.6
PRETER
M 2.15 13.2
116 b/o radha 24 69 145 32.8 primi urban 6 term 2.57 14.4
117 b/o suhasini 28 68 159 27.3 g3p2 rural 7.4 term 2.57 14.3
118 b/o fathima 25 72 158.5 28.5 g2p1 urban 7.8 term 2.56 14.1
119 b/o mary 25 60 167 24.3 g2p1 rural 7.9 term 2.72 15.4
120 b/o renuka 24 66 154 27.8 primi rural 8.6 term 2.67 14.8
121 b/o rathdevi 26 66 154 27.8 g2p1 rural 8.9 term 2.65 15.3
122 b/o keerthana 24 78 161 30.1 primi urban 9 term 3.15 15.1
123 b/o jothi 21 74 156 30.2 primi urban 9.2 term 3.6 14.2
124 b/o rupa 20 70 159 27.7 primi rural 9.3 term 2.43 15.1
125 b/o chinnaponnu 26 71 159.5 27.8 primi urban 9.4 term 2.67 14.1
126 b/o parimalam 28 61 166 22.1 g3p2 rural 9.5 term 2.76 14.6
127 b/o abirami 24 70 161 27 primi urban 9.5 preterm 2.156 14.9
128 b/o  pushpa 26 65 154 25.7 g2p1 rural 9.5 term 2.56 15.7
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129 b/o banu 23 74 154 31.2 primi rural 9.6 preterm 2.145 14.2
130 b/o mala 24 73 158 29.6 primi rural 9.6 term 2.65 14.8
131 b/o shenbagam 25 73 164 27.1 g2p1 urban 9.7 term 2.52 13.6
132 b/o manimegalai 26 74 160 28.9 primi rural 9.7 term 2.67 15.1
133 b/o kanmani 24 69 148 31.5 primi urban 9.9 term 2.78 14.9
134 b/o sindhu 25 64 165 24.4 g2p1 rural 10.1 term 2.56 14.8
135 b/o lalitha 25 70 153 29.9 primi rural 10.1 term 2.31 15.3
136 b/o uma 29 70 154 29.5 g2p1 urban 10.1 preterm 2.154 16.1
137 b/o rani 21 77 158 30.8 primi urban 11.1 term 2.54 16.8
138 b/o revathy 23 72 154.5 30 primi rural 10.1 term 3.22 14.9
139 b/o selvi 24 71 152.5 30.7 primi rural 10.2 preterm 2.24 16.4
140 b/o parvathy 24 67 157 27.2 primi rural 10.2 term 3.23 15.5
141 b/o shanthi 27 58 165 21.3 g2p1 rural 10.2 term 2.67 15.2
142 b/o  vidya 24 62 168 22 g2p1 urban 9.2 term 2.73 15.2
143 b/o kanchana 31 64 157 26 g2p1 urban 10.2 preterm 2.35 15.4
144 b/o sandhya 26 67 157.5 27.2 g2p1 rural 10.2 term 2.45 15.4
145 b/o ponnammaal 27 71 154.5 29.9 g2p1 urban 10.2 term 2.69 15.4
146 b/o maniammai 26 70 149 31.5 primi rural 10.3 term 2.75 15.6
147 b/o revathy 24 60 167 21.5 primi urban 10.3 term 2.54 15.6
148 b/o jamuna 27 63 156.5 25.9 g3p2 rural 10.3 term 2.67 15.6
149 b/o kanthimathi 27 76 157.5 30.8 g2p1 urban 10.3 term 2.6 16.4
150 b/o kanaga valli 24 70 160 27.3 primi urban 10.4 preterm 2.16 16.4
151 b/o punitha 25 66 160 25.8 g2p1 urban 11.2 term 3.36 16.2
152 b/o gowri 30 64 156 26.3 g3p1A1 rural 10.4 term 3.21 15.2
153 b/o poovizhi 26 60 163 22.6 g2p1 rural 10.4 term 2.87 15.4
154 b/o uma 21 59 165 21.7 primi rural 10.4 term 2.75 15.3
155 b/o sumathi 26 68 157 27.6 g2p1 rural 8.4 term 2.56 13.5
156 b/o 24 71 160 27.7 primi rural 10.4 term 2.78 16.4
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bakkialakshmi
157 b/o poovazhagi 28 71 159 28.1 g3p2 rural 10.4 term 2.78 15.5
158 b/o nandhini 28 76 153 32.5 g2p1 urban 11.4 term 2.78 16.2
159 b/o jaya 28 65 153 27.8 g2p1 urban 10.5 term 2.87 14.7
160 b/o swathy 28 72 156 29.6 g3p1A1 rural 6.5 term 2.45 13.1
161 b/o vasugi 28 71 153 30.3 g2p1 urban 10.5 term 2.79 15.8
162 b/o valarmathy 21 66 152 28.6 primi rural 10.5 term 2.54 15.4
163
b/o
muthulakshmi 26 78 158 31.2 g2p1 urban 10.5 term 2.89 16.4
164 b/o sembarutthi 26 71 157 28.8 g2p1 urban 10.5 term 2.57 15.5
165 b/o radha 28 61 164 22.7 g3p2 urban 10.6 preterm 2.25 16.9
166 b/o girija 25 68 159 26.9 primi urban 10.6 term 2.87 15.4
167 b/o janaki 24 68 154 28.7 primi rural 10.6 term 2.9 15.4
168 b/o saroja 27 70 153 29.9 g2p1 urban 10.6 term 2.57 15.8
169 B/O Thenmoli 25 65 156 26.7 Primi rural 11.2 Term 2.3 16
170 b/o malathy 24 60 158 24.03 g2p1 urban 11 term 3.14 16.7
171 b/0 rajalakshmi 27 64 160 25 primi urban 10.8 term 2.86 16.2
172 b/o malarvizhi 25 68 154 28.6 primi urban 9.8 term 2.89 15.2
173 b/o sandhya  20 68 160 26.5 primi urban 9.6 term 2.04 14
174
b/o
vanniyamalar 26 58 162 22.6 primi urban 8.8 term 2 14.8
175 b/o jayakumari 19 66 160 25.7 primi rural 9.1 term 2.73 17.6
176 b/o mohana 30 65 164 24.1 g2p1 rural 10.1 Term 2.78 13.2
177 b/o jemila 24 59 166 23.04 g2p1 urban 12 Term 3.12 21
178 b/o sumitha 30 70 167 25 Primi urban 11.2 Term 2.63 17.2
179 b/o nagabramma 27 52 160 20.3 g3p2 rural 6.4 Term 3.58 13.2
180 b/o meenakshi 26 58 156 23.8 g3p2 urban 11.6 Term 3.24 16.4
181 b/o anitha 25 70 168 24.8 g2p1 rural 11.2 Term 2.9 17
119
182 b/o sathya 23 62 162 23.6 g2p1 urban 12 Term 3.76 16.8
183 b/o kalaichelvy 28 64 168 22.6 g2p1 rural 12 Term 2.59 13.9
184
b/o
veeralakshmi 26 62 164 23.05 Primi rural 11.8 Term 3.06 17.4
185 b/o kavitha 30 95 160 37.1 g3p2l2 rural 10.1 Term 2.5 14.9
186 b/o geetha 28 66 158 26.4 g2p1 rural 10.8 term 2.45 16.6
187 b/o seetha 26 68 164 24.8 g3p2 rural 10.4 Term 2.46 15.2
188
b/o lalitha
krishno 22 22 64 158 25.6 Primi urban 11.1 term 3.1 15.1
189 b/o radha 30 70 168 24.8 g2p1 urban 12.2 Term 2.8 17.2
190 b/o kavya 25 68 156 27.9 primi urban 11.8 Term 2,8 16.4
191 b/o sundari 23 72 166 26.1 g2p1 rural 11 term 2.6 16
192
b/o
vijayalakshmi 24 65 168 23 g2p1 rural 10.6 Term 2.81 16.2
193 b/o varalakshmi 21 62 158 24.83 g2p1 rural 8 Term 2.2 14.1
194 b/o ambika 24 68 166 24.67 g3p2 urban 11.2 Term 2.89 16.2
195 b/o yashoda 26 66 170 22.83 G3P2 rural 7.6 Term 2.78 14.8
196 b/o anjali 24 70 168 24.8 primi rural 11.2 Term 2.6 16.8
197 b/o chitra 24 68 156 27.94 primi rural 11.2 preterm 2.2 15
198 b/o banu 25 72 167 25.81 G2P1 rural 13.2 Term 2.7 17
199 b/o kalaivani 27 58 160 22.65 G2P1 urban 12.2 Term 2.89 16.8
200 b/o kanaga 22 60 156 24.65 G3P1 rural 11.2 Preterm 1.89 16.2
201 b/o saroja 26 58 164 21.56 primi urban 9.8 Term 2.7 14.4
202 b/o vijaya 30 68 169 23.8 G3P2 rural 9.8 Term 3.2 14.4
203 b/okalaiarasi 22 66 158 26.43 G3P1A1 rural 7.1 Term 2.67 14.2
204 b/o malathy 26 70 168 24.8 G2P1 rural 13 Term 3.4 19
205 b/o vennila 26 62 157 25.15 primi urban 12.4 Term 3.3 18.2
206 b/o kavitha 24 66 150 29.33 G2P1 urban 12.6 Term 3.2 17.2
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207 b/o sivapriya 28 70 158 28.04 Primi urban 6.8 Term 2.2 12.2
208 b/o sridivya 22 74 160 28.9 G2P1 urban 11.2 Term 2.7 16.2
209 b/o malathy 27 76 164 28.25 G2P1 urban 11.4 Term 2.8 17.2
210 b/o malarkodi 22 76 167 27.25 Primi rural 7.2 Term 2.8 14.8
211 b/o kalaimani 28 78 168 27.63 G2P1 urban 11.8 Term 3.6 16
212 b/o vasanthi 29 76 168 26.92 G2P1 rural 13.2 Term 3.2 17.8
213 b/o varalakshmi 22 68 160 26.56 primi rural 12.6 Term 3.1 16.4
214 b/o sandhya  26 75 162 28.57 G2P1 rural 12.6 Term 2.6 16.4
215 b/o kaveri 21 66 158 26.43 G2P1 urban 9.6 Term 2.6 14.2
216 b/o manju 26 76 168 26.92 G3P2 rural 9.6 Term 2.1 14.8
217 b/o nagammal 27 68 156 27.94 G2P1 rural 5.8 Term 2.4 13.1
218 b/o nandhini 22 70 158 28.04 G2P1 rural 10.2 Term 3.1 15.6
219 b/o vijaya 28 72 165 26.44 G3P1A1 urban 11.4 Term 2.6 16.8
220 b/o savithri 30 74 162 28.19 G2P1 urban 11.6 Term 2.6 15.2
221
b/o lalitha
krishno 22 26 74 160 28.9 G2P1 urban 12.8 Term 3.1 18.6
222 b/o lakshmi 22 76 156 31.22 primi rural 12.6 Term 2.4 16.2
223 b/o malathy 26 74 162 28.19 G2P1 urban 9.5 Term 2.5 15
224 b/o vijaya 28 64 158 25.63 G4P2A1 rural 8 Term 2.1 14.1
225 B/O Thenmoli 22 62 156 25.47 G2P1 urban 11.2 Term 2.6 15.8
226 b/o maragatham 23 66 152 28.56 G2P1 rural 11.2 Term 2.6 15.6
227 b/o mala 26 74 160 28.9 G2P1 urban 11.2 Term 2.4 16.2
228 b/o karpagam 26 70 160 27.34 primi urban 11.2 Term 3.1 16.8
229 b/o manju 27 76 165 27.91 G2P1 urban 7.8 Term 3.2 13.4
230 b/o sarala 26 74 160 29.68 primi urban 12.1 Term 3.1 17.2
231 b/o vanitha 26 68 152 29.43 primi urban 6.2 Term 2.16 13.8
232 b/o kavitha 21 62 152 26.83 primi urban 7.4 Term 2.1 13.3
233 b/o saranya 26 66 158 28.56 G2P1 rural 11.6 Term 2.3 16.2
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234 b/o sudha 30 76 164 28.25 G3P1A1 urban 12.2 Term 3.1 17.2
235 b/o savitri 24 72 158 28.84 primi urban 11.6 Term 3.1 16.4
236 b/o malar 22 68 158 27.23 G2P1 urban 11.8 Term 3.1 16.4
237 b/o kalaivani 30 72 161 27.77 G3P2 urban 11.4 Term 2.6 15.8
238 b/o jayanthi 23 68 154 28.67 G2P1 rural 10.2 Preterm 1.96 16.2
239 b/o sandhya  22 72 160 28.12 primi urban 9.3 Term 2.7 14.8
240 b/o indrani 23 68 160 26.56 G2P1 rural 7.1 Term 2.4 14.2
241 b/o pramila 26 67 156 27.94 G2P1 rural 12.1 Term 3.1 17.4
242 b/o vennila 26 72 168 25.51 G3P2 rural 11.2 Term 2.16 16.2
243
b/o
muthulakshmi 28 67 170 23.18 primi urban 9.1 Term 3.1 14.8
244 b/o mary 30 64 168 22.67 primi urban 11.2 Term 2.7 15.4
245 b/o sangeetha 28 68 164 25.28 G2P1 urban 7.4 Term 2.8 12.4
246 b/o devi 22 68 152 29.43 G3P2 rural 11.6 preterm 2 16.2
247 b/o manonmani 26 76 168 26.92 G2P1 urban 9.2 Term 2.9 14.2
248 b/o bagya 28 76 152 32.89 primi urban 11.8 Term 2.4 16.7
249 b/o kousalya 22 64 168 22.67 G2P1 urban 6.8 Term 3.2 14
250 b/o kannamma 28 66 168 22.67 G2P1 urban 10.7 Term 3 15.2
251 b/o jabakanni 26 66 152 28.56 G2P1 urban 9.8 Term 2.8 14.1
252 b/o suryakala 23 64 150 29.33 G2P1 urban 11.6 Term 3.1 15.8
253 b/o selvi 26 68 160 26.56 primi urban 12.1 Term 3.16 18.1
254 b/o jaya 22 68 160 26.56 primi urban 6.9 Term 2.2 14.2
255 b/o rajalakshmi 24 66 150 29.33 G2P1 rural 6.1 Term 2.8 11.8
256 b/o kalai 27 76 169 26.61 G2P1 urban 9.8 Term 2.6 15.1
257 b/o suguna 26 68 152 29.43 G2P1 rural 11.6 Term 2.6 16.8
258
b/o
ashtalakshmi 27 67 152 29.43 G2P1 urban 9.2 preterm 2.1 13.6
259 b/o lakshmi 25 72 162 27.4 G2P1 rural 9.6 Term 2.3 14.2
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260 b/o kantha 27 75 163 28.6 primi urban 11.8 Term 2.8 16.4
261 b/o ramani 28 68 156 27.94 G2P1 rural 9.1 Term 3.1 14.1
262 b/o manju 26 72 156 29.58 primi rural 10.2 Term 2.9 12.2
263 b/o shenbagam 26 72 165 26.4 G2P1 urban 6.4 Term 2.7 13.4
264 b/o visalatchi 23 74 162 28.1 G2P1 urban 11.4 Term 2.6 15.1
265 b/o manjula 27 65 172 21.9 G3P2 rural 11.2 Preterm 2.8 15.8
266 b/o megala 26 76 162 28.9 primi urban 11.6 Term 2.9 16.2
267 b/o manju 22 70 165 25.7 primi urban 11.8 Term 2.8 15.4
268 b/o mercy 27 62 156 25.47 G2P1 rural 10.8 Term 2.7 16.2
269 b/o gomathi 27 76 152 32.89 primi rural 6.2 Term 2.7 12.8
270 b/o sangeetha 28 74 162 28.18 G2P1 urban 14.8 Preterm 2.9 16.6
271 b/o rajalakshmi 24 70 165 25.71 primi urban 11.6 Term 2.7 16.1
272 b/o sumathi 26 70 163 26.34 G2P1 rural 12.2 Term 2.8 16.4
273 b/o sakthi 22 68 159 26.56 primi rural 11.8 Term 2.8 16.2
274 b/o shanthi 28 72 165 26.44 G2P1 rural 10.8 Term 2.6 15.8
275 b/o swetha 28 72 158 28.84 G2P1 rural 11.6 Term 2.34 17.8
276 b/o kaveri 30 76 156 30.44 G3P2 urban 11.8 Term 3.1 16.4
277 b/o kasthuri 27 76 152 32.89 G2P1 rural 9.6 Term 2.68 15.4
278 b/o revathi 24 68 168 24.09 G2P1 rural 9.8 preterm 2.9 16.1
279 b/o sundari 25 64 160 25 G2P1 rural 10.6 Term 2.9 16.2
280 b/o mythili 26 68 152 29.43 G2P1 urban 9.6 Term 2.86 14.8
281 b/o gayatri 26 66 152 28.56 G2P1 urban 11.2 Term 2.8 17.2
282 b/o philomena 26 72 152 31.1 G2P1 urban 11.2 Term 2.8 15.8
283 b/o kumari 30 68 152 29.43 primi urban 9.6 Term 3.2 14.2
284 b/o gowri 24 72 156 29.58 primi rural 10.8 Term 2.9 16.6
285 b/o madhavi 24 68 156 27.9 G2P1 rural 11.8 Term 3.1 16.6
286 b/o chitra 23 77 165 28.28 primi rural 10.2 Term 2.4 15.2
287 b/o sheela 30 74 165 27.18 G3P2 urban 11.6 Term 3.2 17.2
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288 b/o swapna 24 66 162 25.14 G2P1 urban 11.2 Term 2.6 17.2
289 b/o praba 22 77 168 27.28 primi rural 10.2 Term 2.4 14.9
290 b/o sridevi 26 66 162 25.14 g2p1 urban 9.8 Term 3.1 15.2
291 b/o usha 24 77 160 30.07 primi urban 10.8 Term 2.8 16.2
292 b/o vanitha 26 76 154 31.22 G2P1 urban 10.6 Term 3.1 16.4
293 b/o gajalakshmi 27 72 156 29.28 G3P1A1 urban 10.6 Term 2.75 16.8
294 b/o malathi 28 72 163 26.44 G3P2 urban 12.2 Term 2.7 18.1
295 b/o preethi 26 70 165 25.71 G3P1A1 rural 10.8 preterm 2.65 16.4
296 b/o ganga 28 75 165 27.54 G2P1 urban 10.4 Term 2.8 17.1
297 b/o mohana 26 76 150 33.73 G2P1 rural 11.2 Term 2.4 16.4
298 b/o deepa 25 66 150 29.33 primi rural 12.1 Term 3.2 17.4
299 b/o manjari 26 68 162 25.91 G3P2 urban 9.8 term 2.5 14.8
300 b/o alamelu 24 58 152 25.1 G2P1 rural 6.6 term 2.4 12.6
301 b/o padma 23 70 156 28.76 primi urban 11.6 term 2.8 16.2
302 b/o varalakshmi 28 74 166 26.85 G2P1 urban 11.6 term 2.85 15.8
303 b/o panjali 30 72
`
165 26.44 G3P2 rural 10.2 term 2.5 15.6
304 b/o mageshwari 23 75 163 28.22 primi rural 11.6 term 3.2 16.1
305 b/o brinda 24 62 150 27.55 primi rural 8.8 term 2.5 14.6
306 b/o manonmani 28 75 158 30.04 G3P1A1 urban 10.6 term 3.1 15.8
307 b/o chitra 25 67 152 28.99 G3P2 rural 11.6 term 3.2 16.1
308 b/o savitha 30 75 160 29.2 G2P1 urban 10.1 term 2.4 15.1
309 b/o karthika 22 70 164 26.02 primi rural 10.2 term 2.6 15.2
310 b/o madhumila  27 68 158 27.2 G2P1 urban 11.8 term 2.2 15.6
311 b/o mageshwari 25 66 148 30.1 primi rural 10.6 term 2.9 15.4
312 b/o uma 26 64 162 24 G2P1 urban 9.2 term 2.4 14.4
313 b/o ambika 26 63 160 24.6 primi rural 9.6 term 2.1 16.1
314 b/o sasi 26 72 164 24 G3P2 urban 11.6 term 2.6 17.2
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315 b/o meenakshi 24 70 156 28.8 primi urban 9.6 term 2.6 14.2
316 b/o sita 26 68 162 25.9 G2P1 rural 10.4 preterm 2.58 15.8
317 b/o vino 28 74 155 30.8 primi rural 10.1 term 2.8 16.1
318 b/o jeya 26 70 165 25.7 primi rural 9.8 term 2.8 15.8
319 b/o radha 24 66 151 29.3 primi urban 12 term 3 17.2
320 b/o usha 28 73 166 26.8 G2P1 urban 10.2 term 3.1 16.4
321 b/o anusiya 24 73 160 28.5 primi rural 6.6 term 3.12 13.6
322 b/o radha 24 62 162 23.6 primi rural 10.6 term 2.56 15.3
323 b/o nadhiya 29 66 146 31 g3p1 rural 10.6 term 2.63 16
324 b/o darshini 30 67 155.4 27.9 g3p2 rural 10.6 term 2.43 15.8
325 b/o priya 27 74 154.5 31.2 g2p1 urban 10.6 term 2.56 16.8
326
b/o
madhumathy 30 64 159 25.3 g3p2 urban 10.6 term 2.53 15.6
327 b/o subitha 26 72 157 29.2 g2p1 urban 8.6 term 2.54 13.5
328 b/o thenmozhi 25 69 157 28 g2p1 urban 9.6 term 2.65 15.5
329 b/o santhi 27 63 158 25.2 g2p1 urban 10.7 preterm 2.26 15.8
330 b/o jayanthi 25 75 149 33.8 g2p1 rural 10.7 term 2.42 15.7
331 b/o juli 27 69 160 27 primi urban 10.7 term 2.37 15.9
332 b/o nagammal 28 70 156.6 28.8 g3p1A1 urban 9.7 term 2.75 15.6
333 b/o dharani 23 72 156 29.6 primi rural 10.8 term 2.64 15.1
334 b/o navya 21 69 157 28 primi rural 10.8 term 2.64 15.5
335 b/o sundari 27 71 160 27.7 g2p1 rural 11 term 2.95 16.3
336 b/o kavitha 24 64 156 26.3 primi rural 11 term 2.98 16.1
337 b/o firoza 26 75 158 30 g2p1 rural 11.1 term 3.12 15.3
338 b/o saraswathi 26 69 160 27 g3p2 rural 11.1 term 2.65 16.3
339 b/o reshma 28 73 160 28.5 g2p1 urban 11.1 term 2.45 17.6
340 b/o anu 22 68 158 27.2 primi urban 11.1 term 2.78 16.8
341 b/o lekha 22 66 159 26.1 primi rural 11.1 term 2.13 16.3
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342 b/o velvizhi 26 74 160 28.9 primi urban 11.1 term 2.65 16.6
343 b/o kalaiarasi 28 72 161 27.8 g2p1 rural 11.1 term 2.65 16.1
344 b/o stella 26 69 164 25.7 primi rural 11.2 term 3.08 16
345 b/o sangeetha 27 65 155.5 27.1 primi urban 11.2 term 2.65 16
346 b/o amulu 21 72 154 30.4 primi rural 11.2 term 2.98 17.4
347 b/o santhoshi 25 75 160 29.3 primi urban 11.2 term 2.56 16.4
348 b/o sakthi 27 75 157 30.4 g2p1 urban 11.3 term 2.54 15.6
349 b/o monisha 31 76 156 31.2 g2p1 urban 11.3 term 2.67 16.4
350 b/o devi bala 26 68 156 27.9 g2p1 urban 11.4 term 2.45 16.2
351
b/o
dhanalakshmi 26 67 159 26.5 primi rural 11.4 term 2.87 16.2
352 b/o chitra 26 68 160 26.6 primi rural 11.4 term 2.95 15.7
353 b/o divya 23 67 156 27.5 primi rural 11.4 term 2.51 15.5
354 b/o nirosha 26 77 154 32.5 g2p1 urban 11.4 term 2.54 16.9
355 b/o gayathri 27 62 161 23.9 g2p1 urban 11.4 preterm 2.21 17
356 b/o lavanya 24 71 154 29.9 primi urban 11.4 term 2.56 16.1
357 b/o malarkodi 21 67 156 27.5 primi urban 11.4 preterm 2.12 16.3
358 b/o gudiya 27 73 159 28.9 g2p1 urban 11.5 term 2.89 15.6
359 b/o ponmani 24 68 156 27.9 primi rural 11.5 term 2.45 16.2
360 b/o viji 19 72 158 28.8 primi urban 11.5 term 2.34 16.6
361 b/o tamilarasi 25 68 156 27.9 primi urban 11.5 term 2.65 15.6
362 b/o sathya 25 69 158 27.6 primi urban 11.5 term 2.54 16.4
363 b/o durgadevi 29 65 156 26 primi urban 11.5 term 2.54 16.5
364
b/o
veeralakshmi 25 72 158 28.8 g2p1 urban 11.5 term 3.2 15.8
365 b/o deepika 25 67 154 28.3 g2p1 urban 11.5 term 2.87 16.4
366
b/o dilshad
begum 21 67 154 28.3 primi rural 11.5 term 2.89 15.7
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367 b/o bhuvana 26 74 156 26.3 g2p1 urban 11.5 preterm 2.14 15.1
368 b/o vinothini 25 68 157 27.9 g2p1 urban 11.6 term 3.35 17.8
369 b/o naveena 21 63 156.5 25.6 primi rural 11.6 term 2.64 16.5
370 b/o ranjani 26 63 158 25.2 g2p1 urban 11.6 preterm 2.14 16.8
371 b/o sarveswari 28 67 164 28.3 g3p2 rural 11.7 term 2.61 16.6
372 b/o anjalai 30 70 159 27.7 g3p2 rural 11.7 term 3.34 15.4
373 b/o vani 26 72 156 29.6 g2p1 urban 11.7 term 2.52 16.9
374 b/o jayadevi 24 68 152 29.4 primi rural 11.7 term 3.13 15.7
375
b/o
kanchanamala 28 72 160.5 28.1 g2p1 urban 11.7 term 2.75 15.7
376 b/o pavithra 21 71 164 26.4 primi urban 11.8 term 2.56 16.5
377 b/o jaya kumari 21 64 162 24.4 primi rural 11.8 term 2.74 16.1
378 b/o leelavathi 25 70 159 27.7 g2p1 urban 11.8 term 2.84 16.4
379 b/o vasanthi 25 73 156.5 29.6 primi urban 11.8 term 2.63 17
380 b/o padmavathy 29 74 157.5 30 g3p1A1 urban 11.8 term 2.65 16.7
381 b/o anjali 24 69 157 28 primi urban 11.8 term 2.78 16.2
382 b/o akila 27 71 155 29.6 g2p1 urban 11.8 term 2.76 16.8
383 b/o kanaga valli 25 74 154 31.2 g2p1 urban 11.9 term 2.45 16.2
384 b/o manjari 26 66 155 27.1 g2p1 rural 12.1 term 2.53 15.8
385 b/o radhika 24 75 154 31.6 primi rural 12.1 term 2.57 17.9
386 b/o devi 26 72 157 29.2 g2p1 urban 12.1 term 2.65 17.5
387 b/o latha 27 76 162 29 primi urban 12.2 term 3.12 17.8
388 b/o karthika 25 70 154 29.5 primi urban 12.2 term 2.98 17.4
389 b/o nivedha 28 68 160 26.6 g2p1 urban 12.2 term 2.67 17.5
390 b/o hemavathy 23 65 156 26.7 primi rural 12.2 term 3.14 16.1
391 b/o swetha 26 70 159 27.7 g2p1 urban 12.4 term 2.54 16.4
392 b/o ganga 27 73 154 30.8 primi urban 12.5 term 2.59 16.7
393 b/o durga 24 64 154 27 g2p1 urban 12.6 term 2.86 15.6
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394
b/o
mahalakshmi 24 75 158 30 primi urban 12.7 term 2.45 17.9
395 b/o vanisree 25 75 160 29.3 primi urban 13.1 term 2.34 18.1
396 b/o yogeswari 26 76 150 33.8 primi urban 13.2 term 2.65 17.8
397 b/o poongothai 26 63 148 28.8 g2p1 urban 12.5 term 2.85 15.9
398 b/opraveena 30 63 156 25.9 g3p2 urban 11.5 term 2.85 15.7
399 b/o kalaichelvi 29 70 158 28 g3p2 urban 11.6 term 2.65 16.2
400 b/o santhi 22 66 156 27.1 primi urban 11 term 2.8 16.2
